Track market-moving stories before they get noisy

On its third quarter of 2026 earnings call, held on Oct. 22, 2026, Ryder (R +2.02%) raised its full-year 2026 comparable earnings per share forecast range to $14.85 to $15.05. The shift toward contractual asset-light operations provides predictable earnings that protect returns during cyclical downturns. Three things management said stand out.

1. Asset-Light Growth Transforms the Revenue BaseSupply Chain Solutions, which handles warehousing and logistics, and Dedicated Transportation Solutions, which supplies customized vehicle fleets, now drive most of the business. This structural expansion reduces reliance on capital-heavy commercial truck leasing.

Our revenue mix has shifted toward Supply Chain and Dedicated, with approximately 60% of 2026 expected revenue generated by these asset-light businesses, compared to 44% in 2018, as a result of organic growth, strategic acquisitions, and innovative technology.
-- John Diez, Chief Executive Officer2. Cash Generation Unlocks Multibillion-Dollar Capital DeploymentLong-term contractual relationships generate steady operating cash flows and de-lever the balance sheet rapidly. This capital capacity gives management room to balance organic fleet investments with share repurchases and strategic acquisitions.

This leaves around $4.5 billion, which equates to approximately 50% of our quarter end market cap, available for flexible deployment to support growth and return capital to shareholders.
-- Cristy Gallo-Aquino, Executive Vice President and Chief Financial Officer3. Commercial Rental Fleet Signals an Inflection PointFleet Management Solutions, which handles vehicle leasing and maintenance, recorded commercial rental fleet utilization of 77%. Improving spot rates and leaner used vehicle inventories are driving higher transactional demand across tractor classes.

We are seeing good activity on the Industrial side, on the Dedicated sales activity. And then Rental, we did see an acceleration in both tractors and trailers, which is indicative of maybe this freight market showing signs of life, which is one of the encouraging signs we saw in the quarter.
-- John Diez, Chief Executive OfficerLooking AheadFreight conditions show early stabilization as commercial fleet utilization trends higher across core operating units. Ryder's long-term contractual model locks in steady pricing and predictable cash generation across market cycles.

And finally, we are encouraged to see benefits across the business from continued strengthening of freight market conditions. Contractual sales remain strong across all three segments, with activity accelerating in Leased and Dedicated.
-- John Diez, Chief Executive OfficerManagement is tracking rental fleet expansion timing and pricing discipline on contractual renewals. Reduced balance sheet leverage positions the company to capture profitable market share as freight demand recovers.

We continue to outperform prior cycles, and our results are benefiting from consistent execution and the strength of our contractual portfolio. We continue to see significant opportunity for profitable growth, supported by secular trends, our operational expertise, and ongoing momentum from multi-year strategic initiatives.
-- John Diez, Chief Executive OfficerThe Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

NEC Presents Phase I/II Results for Individualized Oral Neoantigen Therapy, NECVAX-NEO1 at ESMO 2026

Phase I/II NECVAX-NEO1 trial in patients with triple-negative breast cancer confirm its potential safety and immunogenicity and provide clinical proof-of-concept for the use of this investigational oral bacteria-based DNA neoantigen therapy in high-risk early-stage cancer patients including the perioperative setting as well.

TOKYO, Japan, Oct 23, 2026 - (JCN Newswire) - NEC Bio will be presenting results from the Phase I/II TNBC clinical trial of its orally administered individualized neoantigen therapy, NECVAX-NEO1, used in combination with checkpoint inhibitors (CPIs) and chemotherapy for patients with triple-negative breast cancer (TNBC). The findings are being presented in an e-poster at the ESMO Congress in Madrid, Spain, from October 23 to 27, 2026.

NECVAX-NEO1 is an AI powered individualized bacteria-based oral DNA therapy that combines IMMUNASIGHT(r), NEC Bio's proprietary AI based neoantigen prediction platform for identifying the most immunogenic patient-specific neoepitopes, with TORAPRIME(R), its proprietary oral bacterial neoantigen delivery platform. This therapy is designed to activate a patient's immune system, prompting a T-cell response that can precisely target and eliminate tumor cells based on an individual's unique neoantigens.

In the first cohort of the phase I/II study, 8 patients with TNBC were treated with NECVAX-NEO1 in a neoadjuvant setting. All patients were treated with 2 courses of neoadjuvant chemotherapy and pembrolizumab before the planned surgery. After 12 weeks of chemotherapy/pembrolizumab, NECVAX-NEO1 was added on top, with an optional adjuvant treatment phase after surgery. NECVAX-NEO1 on top of chemotherapy/immunotherapy was generally well tolerated. Five patients achieved pathological complete response at surgery, accompanied by corresponding biomarker changes. In all patients, immunogenic neoepitopes used in NECVAX-NEO1 were detected, as demonstrated by ELISPOT analysis.

Regarding the results of the clinical study, Dr. Heinz Lubenau, CEO of NEC Bio Therapeutics, commented, "Our clinical Phase I/II data are demonstrating promising immune responses in the neoadjuvant treatment of early-stage TNBC patients. The results are encouraging, so we are extending the trial to n=28 patients, including patients in the U.S., as we recently received IND approval to conduct a clinical trial in the country. The additional patients in cohort 2 are being treated with a higher dose of NECVAX-NEO1 on top of Keynote-522 standard of care regimen, which includes pembrolizumab. We look forward to further evaluation of NECVAX-NEO1 as a potential treatment option for cancer patients with high medical need."

Akira Kitamura, CEO, NEC Bio, further commented, "The results presented at ESMO 2026 are an important accomplishment that further strengthens NEC Bio's confidence in the potential of NECVAX-NEO1 as an individualized neoantigen therapy. By combining our proprietary AI-powered neoantigen discovery platform, IMMUNASIGHT(R) with a differentiated neoantigen delivery platform TORAPRIME(R), we aim to deliver highly individualized treatment approaches for patients with cancer. These findings support our continued commitment to advancing innovative therapies that have the potential to improve patient outcomes and expand the possibilities of precision treatment in oncology."

Details of the poster are below:

Poster title: Phase I/II study of neoadjuvant personalized vaccination with NECVAX-NEO1, in combination with pembrolizumab and chemotherapy in early-stage triple-negative breast cancer, evaluating safety, immunogenicity, and preliminary clinical activity NCT06631092

Authors: Peter A. Fasching, Katharina Keller, Oliver Schleicher, Carlo Fremd, Laura Michel, Michael Platten, Isabel Poschke, Ingrid Hulsmeyer, Margarida Garcia, Alvaro Aranguren, Kaidre Bendjama, Daiki Mori, Heinz Lubenau, Andreas Schneeweiss

Poster Number: 4694eP
Date: 23 October 2026

The poster may also be found here: https://www.nec-bio.com/en_DD/img/20261022_ESMO2026_NECVAX-NEO1_05_DE_poster.pdf

Trial details can also be viewed at: NCT06631092

NECVAX-NEO1 is currently under evaluation at additional clinical trial sites in several European countries.

About IMMUNASIGHT(R)

IMMUNASIGHT(R) is NEC Bio's AI-powered neoantigen discovery platform designed to identify and prioritize clinically relevant immune targets for next-generation immunotherapies. By modeling the complete antigen presentation pathway, from mutation identification and processing to presentation, together with immunogenicity, IMMUNASIGHT(R) helps researchers narrow thousands of potential targets to those most likely to elicit meaningful anti-tumor immune responses. The cloud-native platform supports scalable, reproducible, and rapid analysis for oncology research and therapeutic development. IMMUNASIGHT(R) is registered in certain jurisdictions

About TORAPRIME(R)

TORAPRIME(R) is NEC Bio's proprietary oral bacteria-based delivery platform that uses attenuated bacteria to deliver DNA encoding selected neoantigens through the gut immune system. Following oral administration, the platform is designed to induce neoantigen-specific T cell responses and support systemic anti-tumor immune responses. TORAPRIME(R) is the delivery technology underlying NECVAX-NEO1. TORAPRIME(R) is registered in certain jurisdictions.

About NEC Bio

NEC Bio is the biotechnology arm of NEC Corporation, headquartered in the Netherlands, and focused on leveraging state-of-the-art AI technologies to address the world's most pressing healthcare challenges. Leveraging cutting-edge science, data, and innovation, NEC Bio is dedicated to developing personalized therapies designed to transform patient outcomes and improve quality of life globally. With a growing international footprint, NEC Bio includes subsidiaries such as NEC OncoImmunity in Oslo, Norway, and NEC Bio Therapeutics in Mannheim, Germany-each contributing specialized expertise across immunotherapy, precision medicine, and translational research. Together, these entities form a collaborative ecosystem committed to accelerating innovation from discovery to patient impact.
To learn more, visit www.nec-bio.com and follow us on LinkedIn for the latest updates.

About NEC Bio Therapeutics

NEC Bio Therapeutics, established in Mannheim, Germany, focuses on the clinical strategy and development, as well as planning and execution of clinical trials in the oncology area. It is a subsidiary of NEC Bio, the biotech arm of NEC Corporation.

About NEC Corporation

The NEC Group leverages technology to create social value and promote a more sustainable world where everyone has the chance to reach their full potential. NEC Corporation was established in 1899. Today, the NEC Group's approximately 110,000 employees utilize world-leading AI, security, and communications technologies to solve the most pressing needs of customers and society.
For more information, please visit https://www.nec.com, and follow us on LinkedIn and YouTube.

Source: NEC Corporation

Copyright 2026 JCN Newswire . All rights reserved.

Disclosures
I/we have no positions in any stocks mentioned, and have no plans to buy any new positions in the stocks mentioned within the next 72 hours.

Click for the complete disclosure

Are RTX Corporation and Northrop Grumman Ready to Break Out?Ryder System NYSE: R reported third-quarter results that included a 21% increase in comparable earnings per share, citing strategic initiatives, contractual revenue growth and improving conditions in used vehicle sales and commercial rental.

Comparable EPS from continuing operations rose to $4.33, while total operating revenue increased 6% year over year to $2.8 billion, according to Chief Financial Officer Cristy Gallo-Aquino. Free cash flow rose to $992 million from $496 million in the prior-year period, reflecting lower capital expenditures year to date.

Get Ryder System alerts:

MarketBeat Week in Review – 10/12 - 10/16“The Ryder team delivered our eighth consecutive quarter of comparable earnings per share growth,” CEO John Diez said. He attributed the results to execution on the company’s strategy, as well as stronger used-vehicle and rental performance.

Fleet Management Results Improve Fleet Management Solutions operating revenue increased 5%, while earnings before taxes rose 21% to $177 million. The segment benefited from strategic initiatives in ChoiceLease, improving used-vehicle sales and stronger rental performance.

RTX Locks In a Decade of Defense DominanceCommercial rental utilization reached 77%, up 700 basis points from a year earlier, despite a 12% smaller average fleet. Rental pricing increased 4% year over year. Ryder said tractor demand was particularly strong, and it expects rental utilization to remain near third-quarter levels in the fourth quarter.

Fleet Management Solutions’ EBT margin reached 13.2% of operating revenue, which management said was in line with its long-term low-teens target. Tom Havens, president of Fleet Management Solutions, said the quarter marked the first time since the fourth quarter of 2022 that lease, SelectCare and rental each posted year-over-year revenue growth.

Used-vehicle pricing also improved. Tractor pricing rose 19% from a year earlier and 15% sequentially, while truck pricing increased 5% year over year and 6% sequentially. Ryder sold 5,100 used vehicles during the quarter, up 200 units from a year earlier, and reduced used-vehicle inventory to 7,300 units, near the low end of its target range.

The retail channel accounted for 61% of used-vehicle sales volume, compared with 54% a year earlier. Havens said the shift toward retail sales contributed to tractor pricing performance; excluding the retail-wholesale mix change, tractor pricing would likely have risen in the high- to low-double-digit percentage range.

Supply Chain Growth Offsets Dedicated Revenue Pressure Supply Chain Solutions operating revenue increased 9%, driven by new business, higher volumes and pricing. The gains were partially offset by lost automotive business. Segment EBT increased 7% from the prior year, aided by higher e-commerce fulfillment and Ryder Last Mile volumes, though productivity from new business ramp-ups and lower automotive results limited gains.

The Supply Chain Solutions EBT margin was 8.1%, at the company’s long-term high-single-digit target. Steve Sensing, president of Supply Chain Solutions and Dedicated Transportation Solutions, said Ryder’s supply-chain pipeline showed growth opportunities in consumer packaged goods, industrial, healthcare and retail.

Dedicated Transportation Solutions revenue declined 1%, primarily because of a lower year-over-year fleet count, though pricing partially offset the decline. Sequentially, the power fleet increased by 100 units as net sales activity improved. Segment EBT declined from the prior year, reflecting lower revenue and a prior-year workers’ compensation insurance benefit.

Diez said Ryder’s dedicated business is primarily specialized, with 70% to 80% involving specialized operations or private-fleet conversions. The company said it has contractual wage-inflation provisions and driver-wage indices designed to help recover rising labor costs. Sensing said Ryder is seeing mid-single-digit driver wage increases in certain regions, rather than broad nationwide pressure.

Capital Spending and Deployment Plans Ryder maintained its full-year capital expenditure forecast of $2.4 billion. The company reduced its forecast for lease capital expenditures to $1.7 billion, reflecting the timing of lease sales, while increasing its rental capital expenditure forecast to $500 million, up $300 million from its previous estimate.

The rental investment is intended to position Ryder for expected demand growth in 2027. Ryder expects its ending rental fleet to increase 8% sequentially in the fourth quarter and approximately 10% during the second half of 2026. Management said the rental fleet remains below peak levels even after the planned investment.

The company expects approximately $500 million of used-vehicle sale proceeds in 2026 and net capital expenditures of about $1.9 billion. Ryder ended the quarter with leverage of 2.42 times, slightly below its stated target range of 2.5 to 3 times.

Gallo-Aquino said Ryder expects to generate about $10.5 billion from operating cash flow and used-vehicle sale proceeds over three years, creating an estimated $3.5 billion of additional debt capacity. After estimated replacement capital spending and dividends, the company expects roughly $4.5 billion of flexible deployment capacity for growth capital expenditures, share repurchases, acquisitions and investments.

Outlook Raised on Used Vehicle and Rental Strength Ryder raised its full-year 2026 comparable EPS outlook to a range of $14.85 to $15.05, from its prior range of $14.40 to $14.80. The company cited stronger-than-expected third-quarter performance and expected fourth-quarter benefits from used-vehicle sales and rental conditions.

Full-year return on equity outlook increased to 18% to 19%. Free cash flow guidance remained $700 million to $800 million. Fourth-quarter comparable EPS is expected to range from $4.25 to $4.45, compared with $3.59 in the prior-year quarter. Management expects more than $70 million in benefits during 2026 from a multiyear strategic-initiative program launched in 2024. Ryder said it had generated approximately $100 million in benefits during 2024 and 2025 and expects total benefits exceeding $170 million by the end of 2026.

The company also increased its forecast for freight-cycle upturn benefits in 2026 to about $40 million, from $20 million previously. Diez said the additional benefit is being driven primarily by stronger used-vehicle sales, with a smaller contribution from rental improvement. Ryder estimates that benefits from a broader cycle recovery could eventually exceed $250 million, largely from rental and used-vehicle sales, as freight conditions develop.

About Ryder System (NYSE:R)Ryder System, Inc is a transportation and logistics company that provides fleet management, supply chain and dedicated transportation services. Founded in 1933 by James Ryder and headquartered in Miami, Florida, the company serves businesses that rely on commercial vehicles, transportation networks and logistics infrastructure.

Through its Fleet Management Solutions business, Ryder offers full-service leasing, commercial vehicle rental, maintenance, fleet support and related services for trucks, tractors, trailers and other vehicles.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].

Should You Invest $1,000 in Ryder System Right Now?Before you consider Ryder System, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryder System wasn't on the list.

While Ryder System currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Ryder System, Inc. (R) Q3 2026 Earnings Call October 22, 2026 11:00 AM EDT

Company Participants

Calene Candela - Vice President of Investor Relations
John Diez - CEO & Director
Cristina Gallo-Aquino - CFO, EVP & Principal Accounting Officer
John Sensing - President of Global Supply Chain Solutions & Dedicated Transportation Solutions
Tom Havens - President of Global Fleet Management Solutions

Conference Call Participants

Jordan Alliger - Goldman Sachs Group, Inc., Research Division
Brian Ossenbeck - JPMorgan Chase & Co, Research Division
Scott Group - Wolfe Research, LLC
Nancy Hipp - Morgan Stanley, Research Division
Brandon Oglenski - Barclays Bank PLC, Research Division
Robert Salmon - Wells Fargo Securities, LLC, Research Division
Bascome Majors - Stephens Inc., Research Division
Jeffrey Kauffman - Citizens JMP Securities, LLC, Research Division
Benjamin Mohr Mok - Citigroup Inc., Research Division

Presentation

Operator

Good morning, and welcome to the Ryder System Third Quarter 2026 Earnings Release Conference Call. Today's call is being recorded. If you have any objections, please disconnect at this time. I would now like to introduce Ms. Calene Candela, Vice President, Investor Relations for Ryder. Ms. Candela, you may begin.

Calene Candela
Vice President of Investor Relations

Thank you. Good morning, and welcome to Ryder's Third Quarter 2026 Earnings Conference Call. I'd like to remind you that during this presentation, you'll hear some forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.

These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances. Actual results may differ materially from these expectations due to changes in economic, business, competitive, market, political and regulatory factors. More detailed information about these factors and a reconciliation of each non-GAAP financial measure to the nearest GAAP measure is contained in this morning's earnings release, earnings call presentation and in Ryder's filings with the Securities and Exchange Commission, which are available on Ryder's website.

Ryder (R - Free Report) came out with quarterly earnings of $4.33 per share, beating the Zacks Consensus Estimate of $4.17 per share. This compares to earnings of $3.57 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +3.84%. A quarter ago, it was expected that this truck leasing company would post earnings of $3.7 per share when it actually produced earnings of $3.73, delivering a surprise of +0.81%.

Over the last four quarters, the company has surpassed consensus EPS estimates three times.

Ryder, which belongs to the Zacks Transportation - Equipment and Leasing industry, posted revenues of $3.43 billion for the quarter ended September 2026, surpassing the Zacks Consensus Estimate by 1.02%. This compares to year-ago revenues of $3.17 billion. The company has topped consensus revenue estimates two times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Ryder shares have added about 25.6% since the beginning of the year versus the S&P 500's gain of 13.3%.

What's Next for Ryder?While Ryder has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Ryder was favorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #2 (Buy) for the stock. So, the shares are expected to outperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $4.32 on $3.5 billion in revenues for the coming quarter and $14.74 on $13.37 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Transportation - Equipment and Leasing is currently in the top 18% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Another stock from the same industry, Willis Lease Finance (WLFC - Free Report) , has yet to report results for the quarter ended September 2026.

This jet engine lessor is expected to post quarterly earnings of $1.40 per share in its upcoming report, which represents a year-over-year change of +29.6%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.

Willis Lease Finance's revenues are expected to be $202.76 million, up 10.6% from the year-ago quarter.

Brisbane, Queensland, Australia--(Newsfile Corp. - October 21, 2026) - Graphene Manufacturing Group Ltd. (TSXV: GMG) (OTCQX: GMGMF) ("GMG" or the "Company") is pleased to announce that it has commenced providing its fast-charging G®CELLS battery pouch cells to potential customers for early-stage testing and evaluation. The next generation graphene battery technology is being developed by GMG under a Joint Development Agreement with Rio Tinto, one of the world's largest metals and mining groups, and with the support of the Battery Innovation Center of Indiana ("BIC Indiana") in the United States of America.

Customer Sampling Program
GMG has dispatched the first set of what is expected to be over 100 G®CELLS before the end of 2026 of ~ 1.5 Ah pouch format cells designed for 6 minute charging to a number of potential customers, representing various initial target sectors, including defence and heavy mobile equipment amongst others. The cells were made with battery materials developed, manufactured and supplied by GMG from its Brisbane Battery Development Centre and assembled by BIC Indiana.

This customer sampling program represents early testing of the performance of G®CELLS. Its purpose is to allow potential customers to independently evaluate cell characteristics such as fast-charge capability, cycle life, energy efficiency and behaviour in their own test environments and duty cycles, and to provide feedback to GMG to guide ongoing cell development, optimisation and scale-up. The cells are pre-commercial evaluation samples and are not being supplied for use in commercial products.

This step is consistent with GMG's battery cell roadmap, which calls for the testing of cells with customers in 2026.

Technology Readiness — BTRL 4
The battery technology readiness level ("BTRL") of G®CELLS remains at Level 4. At BTRL 4, the cell technology has been demonstrated and validated in a laboratory environment, and work continues on optimising the electrochemical performance of the pouch cells. Customer evaluation at this stage is intended to generate early, application-relevant performance data and to inform the development steps required to progress the technology to higher readiness levels. Through collaboration with BIC Indiana, it is anticipated that the battery technology readiness will ultimately progress to BTRL 7 and 8, since the equipment and processes needed to produce G®CELLS are the same as those employed to manufacture lithium-ion batteries, though no definitive timeline for achievement can be provided at this time nor can any assurance be provided that GMG's battery technology will ever achieve BTRL 7 or 8.

Recent Performance Results
The cells being sampled follow GMG's most recent battery performance announcement on October 8, 2026¹, in which BIC Indiana data showed that G®CELLS:

Cycled with no performance reduction after 1,000 cycles (as at October 7, 2026) while being charged and discharged in 6 minutes (at 7C);Achieved an energy density of 58 Wh/kg while being charged in 6 minutes (at 10C), a 48% increase over the previously reported 39 Wh/kg; andDemonstrated 94% energy efficiency at high charge and discharge rates, compared with 64% for a tested Lithium Titanate Oxide (LTO) cell.These results were generated in a laboratory setting. Performance in customer testing may differ depending on test protocols, operating conditions and application requirements.

Comments

Craig Nicol, Chief Executive Officer and Managing Director of GMG, commented: "Putting G®CELLS into the hands of potential customers is an important milestone on our battery roadmap. Our technology is at BTRL 4, and this is early testing — but it is exactly the right time to get real-world feedback. Customers will test our cells against their own requirements, and what we learn will directly shape our next development sprints on energy density, 10C cycle life and larger cell formats. I want to thank the teams at BIC Indiana, our partners at Rio Tinto, and the companies who have agreed to evaluate our cells."

Bob Galyen, GMG Director and former Chief Technology Officer of CATL, commented: "In my experience, getting sample cells to customers early is one of the most valuable steps in any battery development program. Laboratory data tells you what a chemistry can do — customer testing tells you what it needs to do. At BTRL 4, G®CELLS have already shown fast-charge durability and energy efficiency that are rare at this stage of development. Independent evaluation by potential customers, under their own protocols and duty cycles, will give the team the feedback needed to prioritise the next round of optimisation and to plan the path to larger formats and higher readiness levels."

Jack Perkowski, Chairman of GMG, commented: "Sending G®CELLS to potential customers marks the point where our battery program begins to engage directly with the market. The Board is clear that this is early testing at BTRL 4, and we see it as a disciplined, necessary step — one that allows customers to tell us what matters most in their applications before we commit to the next phase of scale-up. With the continued support of Rio Tinto and BIC Indiana, I believe GMG is building the right foundations to move this technology toward commercial relevance, and the Board will continue to support management through the testing and optimisation work ahead."

Next Steps

GMG will work with the evaluating companies to collect test data and feedback over the coming months. In parallel, the Company will continue to optimise G®CELLS energy density and fast-charge cycle life and progress the scale-up of cell sizes. GMG intends to update the market on material outcomes of the customer testing programs as appropriate. Please see the following webpage for further details about the graphene batteries. The G®CELLS are in pouch format — as seen in Figure 1. The launch video link for G®CELLS is shown in Figure 2.

Figure 1: G Cell Pouch Cell Battery

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/8082/320113_f616855504120b43_001full.jpg

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/8082/320113_f616855504120b43_002full.jpg

Cannot view this video? Visit:
Launch video: https://youtu.be/pfHhh5-TLyU

Figure 2: G®CELLS Launch Video

About BIC Indiana:
BIC Indiana is a collaborative initiative designed to incorporate leadership from renowned universities, government agencies, and commercial enterprises. BIC Indiana is a public-private partnership and a not-for-profit organization focusing on the rapid development, testing and commercialization of safe, reliable and lightweight energy storage systems for defense and commercial customers. BIC Indiana is a unique organization that has been leading battery cell development for world leading battery companies for over 10 years and has carried out over 500 battery development projects.

About GMG
GMG is an Australian based clean-technology company which develops, makes and sells energy saving and energy storage solutions, enabled by graphene manufactured via in house production process. GMG uses its own proprietary production process to decompose natural gas (i.e. methane) into its natural elements, carbon (as graphene), hydrogen and some residual hydrocarbon gases. This process produces high quality, low cost, scalable, 'tuneable' and low/no contaminant graphene suitable for use in clean-technology and other applications.

The Company's present focus is to de-risk and develop commercial scale-up capabilities, and secure market applications. In the energy savings segment, GMG has initially focused on graphene enhanced heating, ventilation and air conditioning ("HVAC-R") coating (or energy-saving coating) which is now being marketed into other applications including electronic heat sinks, industrial process plants and data centres. Another product GMG has developed is the graphene lubricant additive focused on saving liquid fuels initially for diesel engines. GMG has also developed a graphene water based coolant additive focused on increasing heat transfer and reducing bacterial growth in cooling water circuits.

In the energy storage segment, GMG is working collaboratively with financial support from the Australian Government to progress R&D and commercialization of GMG Graphene Batteries. GMG has also developed a graphene additive slurry that is aimed to improve the performance of lithium-ion batteries.

GMG's 4 critical business objectives are:

Produce Graphene and improve/scale cell production processesBuild Revenue from Energy Savings ProductsDevelop Next-Generation Battery Develop Supply Chain, Partners & Project Execution CapabilityFor further information please contact:

www.graphenemg.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this news release.

Cautionary Note Regarding Forward-Looking Statements

This news release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. Forward-looking statements relate to future events or future performance and reflect the expectations or beliefs of management of the Company regarding future events. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as "intends", "expects" or "anticipates", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "should", "would" or will "potentially" or "likely" occur.

This information and these statements, referred to herein as "forward-looking statements", are not historical facts, are made as of the date of this news release and include, without limitation: statements regarding the customer sampling and evaluation program and the feedback and data expected from it; statements that G®CELLS are fast charging and that graphene can be used to increase their performance and cycle life; statements regarding the Company's ability to further improve the energy density, cycle life (including at a 10C charge rate) and energy efficiency of G®CELLS, and to scale the cell size; expectations that G®CELLS will progress to BTRL 7 and 8; expectations for R&D and commercialisation of GMG Graphene Batteries; GMG's focus on graphene enhanced heating, ventilation and air conditioning coating in the energy savings segment, saving liquid fuels for diesel engines and increasing heat transfer and reducing bacterial growth in colling water circuits; GMG's 4 critical business objectives; statements attributed to Craig Nicol, Bob Galyen and Jack Perkowski regarding the customer testing program, the performance of G®CELLS and the Company's development path; and the Company's four critical business objectives.

Such forward-looking statements are based on a number of assumptions of management, including, without limitation: that potential customers will test the cells and provide useful feedback; that customer testing results will be consistent with laboratory results; assumptions as to charging time, energy density, energy efficiency, cycle life, safety and thermal behaviour of GMG Graphene Batteries; that GMG Graphene Batteries will progress to BTRL 7 and 8; that a range of global companies in a variety of industries will be interested in working with GMG; that the service agreement with BIC Indiana will enable the Company to optimize its cell design and battery manufacturing equipment; and that the Company will be able to meet its overall timeline on the battery cell roadmap.

Additionally, forward-looking information involves a variety of known and unknown risks, uncertainties and other factors which may cause the actual plans, intentions, activities, results, performance or achievements of GMG to be materially different from any future plans, intentions, activities, results, performance or achievements expressed or implied by such forward-looking statements. Such risks include, without limitation: that potential customers will not complete testing, or that customer test results will not replicate the laboratory performance reported by the Company; that customer evaluation will not lead to further commercial engagement, offtake or sales; that GMG Graphene Batteries cannot be produced at lower cost, or that any of the assumptions as to charging time, energy density, energy efficiency, cycle life, scaling of the cell size, safety, thermal runaway risk and the need for a thermal management system cannot be achieved; that GMG Graphene Batteries will not progress to BTRL 7 and 8; that the Company will not be able to optimize the electrochemical behaviour of the pouch cell through laboratory experimentation or at all; that the Company will not be able to meet its overall timeline on the battery cell roadmap; that the Joint Development Agreement with Rio Tinto will not continue on the terms or timeline currently anticipated; that the battery will need further testing and approval to international battery standards and regulations before sale; unexpected development and production challenges; unanticipated costs; the volatility of global capital markets; and the risk factors set out under the heading "Risk Factors" in the Company's annual information form dated November 04, 2025, available for review on the Company's profile at www.sedarplus.ca.

Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. The Company does not undertake to update any forward-looking statement, forward-looking information or financial outlook that is incorporated by reference herein, except in accordance with applicable securities laws.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/320113

Source: Graphene Manufacturing Group Ltd.

Ready to Announce with Confidence?
Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

In its upcoming report, Ryder (R - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $4.17 per share, reflecting an increase of 16.8% compared to the same period last year. Revenues are forecasted to be $3.4 billion, representing a year-over-year increase of 7.2%.

The consensus EPS estimate for the quarter has been revised 0.2% higher over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.

Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.

While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.

With that in mind, let's delve into the average projections of some Ryder metrics that are commonly tracked and projected by analysts on Wall Street.

Analysts expect 'Operating Revenue- Fleet Management Solutions' to come in at $1.32 billion. The estimate points to a change of +2.8% from the year-ago quarter.

The average prediction of analysts places 'Operating Revenue- Dedicated Transportation Solutions' at $461.03 million. The estimate indicates a change of +0.7% from the prior-year quarter.

It is projected by analysts that the 'Operating Revenue- Supply Chain Solutions' will reach $1.11 billion. The estimate suggests a change of +7.2% year over year.

The collective assessment of analysts points to an estimated 'Revenues- Supply Chain Solutions (SCS)- Subcontracted transportation and fuel' of $388.56 million. The estimate indicates a change of +12.3% from the prior-year quarter.

According to the collective judgment of analysts, 'Revenues- Fleet Management Solutions' should come in at $1.58 billion. The estimate indicates a year-over-year change of +8.1%.

The consensus estimate for 'Revenues- Fleet Management Solutions- SelectCare and other' stands at $174.77 million. The estimate suggests a change of +5.9% year over year.

The combined assessment of analysts suggests that 'Revenues- Dedicated Transportation Solutions' will likely reach $609.87 million. The estimate indicates a year-over-year change of +7%.

The consensus among analysts is that 'Revenues- Fleet Management Solutions- Commercial rental' will reach $241.69 million. The estimate points to a change of -0.1% from the year-ago quarter.

Analysts' assessment points toward 'Revenues- Fleet Management Solutions- ChoiceLease' reaching $901.21 million. The estimate indicates a change of +3% from the prior-year quarter.

Analysts predict that the 'Revenues- Fleet Management Solutions- Fuel services' will reach $265.99 million. The estimate suggests a change of +45.4% year over year.

Analysts forecast 'Revenues- Supply Chain Solutions' to reach $1.50 billion. The estimate suggests a change of +8.5% year over year.

Based on the collective assessment of analysts, 'Commercial rental - Rental Utilization - Power Units' should arrive at 75.0%. Compared to the current estimate, the company reported 70.0% in the same quarter of the previous year.

View all Key Company Metrics for Ryder here>>>

Over the past month, shares of Ryder have returned -0.5% versus the Zacks S&P 500 composite's +0.7% change. Currently, R carries a Zacks Rank #2 (Buy), suggesting that it may outperform. the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .

Shares of Ryder System, Inc. (NYSE:R – Get Free Report) have been assigned an average rating of “Moderate Buy” from the twelve ratings firms that are presently covering the stock, MarketBeat Ratings reports. Four analysts have rated the stock with a hold recommendation, seven have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average 1 year price target among brokers that have issued ratings on the stock in the last year is $284.12.

Several research analysts have issued reports on R shares. Stephens raised Ryder System to a “strong-buy” rating in a research report on Wednesday, July 8th. Susquehanna cut their price target on Ryder System from $310.00 to $280.00 and set a “positive” rating for the company in a research note on Friday, October 2nd. Weiss Ratings reaffirmed a “buy (b)” rating on shares of Ryder System in a research report on Monday, August 24th. Janney Montgomery Scott set a $285.00 price target on shares of Ryder System in a research report on Thursday, October 8th. Finally, Wells Fargo & Company increased their price objective on shares of Ryder System from $290.00 to $300.00 and gave the stock an “overweight” rating in a research note on Friday, July 24th.

Check Out Our Latest Report on R

Institutional Trading of Ryder System Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Courier Capital LLC boosted its position in shares of Ryder System by 96.6% in the third quarter. Courier Capital LLC now owns 26,454 shares of the transportation company’s stock worth $6,028,000 after purchasing an additional 12,995 shares during the period. Wedmont Private Capital increased its stake in shares of Ryder System by 8.9% in the third quarter. Wedmont Private Capital now owns 1,109 shares of the transportation company’s stock worth $261,000 after purchasing an additional 91 shares in the last quarter. Monument Capital Management increased its stake in shares of Ryder System by 1.7% in the third quarter. Monument Capital Management now owns 9,590 shares of the transportation company’s stock worth $2,185,000 after purchasing an additional 162 shares in the last quarter. GAMMA Investing LLC raised its position in shares of Ryder System by 12.0% during the 3rd quarter. GAMMA Investing LLC now owns 2,013 shares of the transportation company’s stock valued at $459,000 after purchasing an additional 216 shares during the period. Finally, Farther Finance Advisors LLC raised its position in shares of Ryder System by 14.8% during the 3rd quarter. Farther Finance Advisors LLC now owns 878 shares of the transportation company’s stock valued at $200,000 after purchasing an additional 113 shares during the period. 87.47% of the stock is owned by hedge funds and other institutional investors. Ryder System Price Performance NYSE R opened at $237.41 on Thursday. The stock has a market capitalization of $9.10 billion, a price-to-earnings ratio of 19.32 and a beta of 1.05. Ryder System has a 1-year low of $157.67 and a 1-year high of $284.25. The company has a debt-to-equity ratio of 1.91, a current ratio of 0.65 and a quick ratio of 0.65. The business’s fifty day moving average price is $244.58 and its 200-day moving average price is $247.41.

Ryder System (NYSE:R – Get Free Report) last issued its quarterly earnings data on Thursday, July 23rd. The transportation company reported $3.73 EPS for the quarter, topping the consensus estimate of $3.69 by $0.04. The company had revenue of $2.69 billion during the quarter, compared to analyst estimates of $3.29 billion. Ryder System had a return on equity of 18.28% and a net margin of 3.88%. Ryder System’s revenue was up 5.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $3.32 earnings per share. Ryder System has set its FY 2026 guidance at 14.400-14.800 EPS and its Q3 2026 guidance at 4.000-4.200 EPS. On average, equities analysts predict that Ryder System will post 14.74 earnings per share for the current year.

Ryder System Dividend Announcement The firm also recently announced a quarterly dividend, which will be paid on Friday, December 18th. Investors of record on Monday, November 23rd will be given a dividend of $1.01 per share. This represents a $4.04 annualized dividend and a yield of 1.7%. The ex-dividend date is Monday, November 23rd. Ryder System’s payout ratio is 32.87%.

About Ryder System (Get Free Report)

Ryder System, Inc is a transportation and logistics company that provides fleet management, supply chain, and dedicated transportation solutions. Its services include commercial vehicle leasing and rental, fleet maintenance, transportation management, warehousing, distribution, and delivery services.

The company serves businesses across industries through operations in the United States, Canada, and Mexico. Ryder also supports e-commerce and retail customers with last-mile delivery, fulfillment, and related logistics services, and sells used commercial vehicles through its network of vehicle sales centers and online channels.

Founded in 1933 by James Ryder, the company is headquartered in Miami, Florida.

Further Reading Five stocks we like better than Ryder System Tesla Wants to Make Its Own Chips—What Could Go Wrong? IREN Limited’s AI Pivot Gains Traction—But Can Its Data Centers Deliver? PBF Energy’s Stunning Rally Faces a Critical Test Citi Stock Falls Despite Earnings Beat: What Investors Need to Know

Receive News & Ratings for Ryder System Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryder System and related companies with MarketBeat.com's FREE daily email newsletter.

Bremen, Indiana--(Newsfile Corp. - October 15, 2026) - Digger Specialties Inc. (DSI), the industry's leader in the production of aluminum railing, offers property owners a choice of two elegant cable railing systems. Cable railing has become an increasingly popular option for decks, patios, balconies, and terraces as well as outdoor and indoor stairways. What distinguishes cable railing from traditional railing systems is the use of thin infill cables that provide wide open vistas of the surrounding landscape. Westbury cable railings are available in either horizontal or vertical cables. DSI's cable railings are part of the most extensive line of aluminum railing that includes eight systems and a selection of twenty two design options.

Westbury Bella Cavo® Horizontal Cable Railing
Bella Cavo railing offers a sleek upscale design with thin stainless-steel cables framed by durable aluminum posts. This design maximizes views while providing a modern aesthetic appearance. Bella Cavo aluminum and stainless-steel cable railing comes in a choice of 4, 6 and 8 foot sections in either 36 or 42 inch heights. Matching adjustable 36 and 48 inch wide gates are available. In addition to distinctive architectural elements, Bella Cavo incorporates labor-saving installation features that lower installed costs.

Westbury VertiCable® Vertical Cable Railing
Since its introduction in 2015, DSI's Westbury VertiCable railing has achieved a high level of marketplace preference due to its unique design incorporating aluminum rails and posts with thin vertical stainless-steel cable infills. Available in 36 and 42 inch heights, Westbury VertiCable sections come in 4, 5, 6, 7 and 8 foot lengths with the option of choosing matching single or double gates. Designed with thin cable infills spaced 3" apart, Westbury VertiCable provides an added measure of safety for pets and children. VertiCable railing comes in pre-assembled sections which result in significant labor savings when compared to most cable railing systems.

Westbury Bella Cavo and VertiCable railing systems are available in an industry leading 12 colors with the option of textured or non-textured surfaces. DSI utilizes a proprietary 10 step AAMA 2604 powder coating process in the production of Westbury railing systems. Westbury Bella Cavo and VertiCable railing systems are backed by DSI's lifetime limited warranty. For more detailed information about Westbury Bella Cavo and VertiCable cable railing systems or other aluminum railings and products, visit diggerpecialties.com.

Lawrence G. Boyts, DSI Vice President of Sales and Marketing stated that "Home and property owners' interest in cable railing have increased substantially during the past decade. To meet the growing demand, DSI features horizontal and vertical cable railing systems that enhance the beauty of outdoor and indoor spaces."

Bella Cavo Horizontal Cable Railing

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/8201/318805_7fe4db30146f3b20_002full.jpg

VertiCable Vertical Cable Railing

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/8201/318805_7fe4db30146f3b20_003full.jpg

####

DSI is a leading manufacturer of aluminum and vinyl railing, fencing, gates, aluminum architectural columns, and outdoor lighting. For more information about DSI's products, visit diggerspecialties.com.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/318805

Source: Digger Specialties Inc.

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

Key Takeaways Ryder System shares gained 32.1% in a year, outpacing the equipment and leasing industry's 9.3% growth.R's relocated New Jersey truck centers enhance market reach, customer access and operational efficiency.R returned $664 million to shareholders in 2025, including $519M in buybacks & $145M in dividends. Ryder System (R - Free Report) is benefiting from its proactive expansion initiatives that are boosting the company’s operational efficiency. The company’s commitment to shareholders is encouraging and bodes well for its prospects. Due to these tailwinds, R shares have performed impressively on the bourse. If you have not taken advantage of its share price appreciation yet, it’s time to do so.

Let’s delve deeper.

Factors Favoring R StockNorthward Earnings Estimate Revision: The Zacks Consensus Estimate for earnings per share (EPS) has been revised upward by 14.09% year over year for 2026. For 2027, the consensus mark for EPS has moved 21.5% north over the same time frame. The favorable estimate revisions indicate brokers’ confidence in the stock.

Robust Price Performance: A look at the company’s price trend reveals that its shares have gained 32.1% over the past year, surpassing the Zacks Transportation - Equipment and Leasing industry’s 9.3% growth.

Image Source: Zacks Investment Research

Positive Earnings Surprise History: Ryder System has an encouraging earnings surprise history. The company's earnings outpaced the Zacks Consensus Estimate in three of the trailing four quarters and missed once in the remaining, delivering an average surprise of 2.53%.

Solid Zacks Rank: R currently carries a Zacks Rank #2 (Buy).

Bullish Industry Rank: The industry to which R belongs currently has a Zacks Industry Rank of 37 (out of 247). Such a favorable rank places it in the top 15% of Zacks Industries. Studies show that 50% of a stock’s price movement is directly related to the performance of the industry group to which it belongs.

A mediocre stock within a strong group is likely to outperform a robust stock in a weak industry. Reckoning the industry’s performance becomes imperative in this context.

Growth Factors: Ryder System is benefiting from its proactive expansion initiatives, strengthening its presence in the Northeast through new and relocated used truck centers in Newark and North Bergen, NJ. These investments enhance customer access to major ports, freight corridors and distribution hubs, positioning the company closer to key logistics markets. The Newark facility is also expected to improve operational efficiency by bringing multiple fleet management solutions under one roof, while the North Bergen location expands Ryder’s reach into a new market south of the George Washington Bridge. These developments could support used vehicle sales and reinforce the company’s integrated transportation service offering.

Ryder’s 2026 E-commerce Consumer Study highlights shifting consumer preferences, with increasing AI adoption, faster delivery expectations and growing demand for seamless omnichannel fulfillment. With 64% of shoppers using AI-assisted tools and 39% expecting delivery within one to two days, retailers face mounting pressure to improve logistics capabilities and fulfillment efficiency. Additionally, the growing popularity of alternative pickup options and flexible returns underscores the importance of integrated supply chain solutions.

These trends create growth opportunities for Ryder’s e-commerce fulfillment, last-mile delivery and omnichannel logistics services as retailers prioritize speed, convenience and customer satisfaction. However, rising delivery expectations and demand for free returns could increase operating costs and pressure profitability. Ryder’s ability to leverage technology-driven logistics solutions and operational efficiencies could strengthen its competitive position and support long-term growth.

Moreover, R’s focus on returning capital to shareholders through dividends and buybacks aligns with its strategy of maintaining a balanced and sustainable growth model. Ryder System returned $456 million in cash to shareholders in 2024 and increased total capital returns to $664 million in 2025, including $519 million in share repurchases and $145 million in cash dividends. The company consistently increased cash dividend payments from $128 million in 2023 to $135 million in 2024 and $145 million in 2025, reflecting strong cash generation and continued emphasis on shareholder returns.

Other Stocks to ConsiderInvestors interested in the Zacks Transportation sector may consider other top-ranked stocks like Wabtec (WAB - Free Report) and Herc Holdings (HRI - Free Report) .

WAB currently carries a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

WAB has an expected earnings growth rate of more than 21.4% for 2026.  The company has an encouraging earnings surprise history. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, delivering an average beat of 4.18%.

Herc Holdings currently sports a Zacks Rank #1.

HRI has a negative expected earnings growth rate of 7.36% for the current year. However, the company has an encouraging earnings surprise history. Its earnings topped the Zacks Consensus Estimate in each of the trailing four quarters, delivering an average beat of 60.64%.

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens.

Zacks Premium includes access to the Zacks Style Scores as well.

What are the Zacks Style Scores? The Zacks Style Scores, developed alongside the Zacks Rank, are complementary indicators that rate stocks based on three widely-followed investing methodologies; they also help investors pick stocks with the best chances of beating the market over the next 30 days.

Each stock is given an alphabetic rating of A, B, C, D or F based on their value, growth, and momentum qualities. With this system, an A is better than a B, a B is better than a C, and so on, meaning the better the score, the better chance the stock will outperform.

The Style Scores are broken down into four categories:

Value ScoreFor value investors, it's all about finding good stocks at good prices, and discovering which companies are trading under their true value before the broader market catches on. The Value Style Score utilizes ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and a host of other multiples to help pick out the most attractive and discounted stocks.

Growth ScoreWhile good value is important, growth investors are more focused on a company's financial strength and health, and its future outlook. The Growth Style Score takes projected and historic earnings, sales, and cash flow into account to uncover stocks that will see long-term, sustainable growth.

Momentum ScoreMomentum trading is all about taking advantage of upward or downward trends in a stock's price or earnings outlook, and these investors live by the saying "the trend is your friend." The Momentum Style Score can pinpoint good times to build a position in a stock, using factors like one-week price change and the monthly percentage change in earnings estimates.

VGM ScoreIf you want a combination of all three Style Scores, then the VGM Score will be your friend. It rates each stock on their combined weighted styles, helping you find the companies with the most attractive value, best growth forecast, and most promising momentum. It's also one of the best indicators to use with the Zacks Rank.

How Style Scores Work with the Zacks Rank The Zacks Rank, which is a proprietary stock-rating model, employs earnings estimate revisions, or changes to a company's earnings expectations, to make building a winning portfolio easier.

#1 (Strong Buy) stocks have produced an unmatched +23.86% average annual return since 1988, which is more than double the S&P 500's performance over the same time frame. However, the Zacks Rank examines a ton of stocks, and there can be more than 200 companies with a Strong Buy rank, and another 600 with a #2 (Buy) rank, on any given day.

With more than 800 top-rated stocks to choose from, it can certainly feel overwhelming to pick the ones that are right for you and your investing journey.

That's where the Style Scores come in.

To have the best chance of big returns, you'll want to always consider stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B, which will give you the highest probability of success. If you're looking at stocks with a #3 (Hold) rank, it's important they have Scores of A or B as well to ensure as much upside potential as possible.

The direction of a stock's earnings estimate revisions should always be a key factor when choosing which stocks to buy, since the Scores were created to work together with the Zacks Rank.

Here's an example: a stock with a #4 (Sell) or #5 (Strong Sell) rating, even one with Style Scores of A and B, still has a downward-trending earnings outlook, and a bigger chance its share price will decrease too.

Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.

Stock to Watch: Ryder (R - Free Report) Ryder System, Inc., a Florida-based corporation founded in 1933, is a provider of integrated logistics and transportation solutions. Ryder’s customers range from small businesses to large international enterprises. They are drawn from a wide variety of industries, the most significant of which include automotive, electronics, transportation, grocery, lumber and wood products, food service and home furnishing.

R is a #2 (Buy) on the Zacks Rank, with a VGM Score of A.

Additionally, the company could be a top pick for growth investors. R has a Growth Style Score of B, forecasting year-over-year earnings growth of 14.1% for the current fiscal year.

One analyst revised their earnings estimate higher in the last 60 days for fiscal 2026, while the Zacks Consensus Estimate has increased $0.00 to $14.74 per share. R also boasts an average earnings surprise of +2.5%.

With a solid Zacks Rank and top-tier Growth and VGM Style Scores, R should be on investors' short list.

Engagement with leading orthopedic surgeons and cartilage repair specialists highlights growing awareness of GelrinC's off-the-shelf regenerative technology

GelrinC is CE Mark approved in Europe, where Regentis is expanding its network of Centers of Excellence to support surgeon training and commercialization efforts

European clinical sites also support the Company's ongoing U.S. FDA pivotal Phase III trial

HERZLIYA, ISRAEL / ACCESS Newswire / October 12, 2026 / Regentis Biomaterials Ltd. ("Regentis" or the "Company") (NYSE American:RGNT), a regenerative medicine company focused on innovative tissue repair solutions, today announced strong interest and engagement from orthopedic surgeons, physicians and cartilage repair specialists who visited the Company's booth at the 8th International Cartilage Regeneration & Joint Preservation Society (ICRS) Summit, held October 8-10, 2026, in Porto, Portugal.

The Summit, themed "Joint Preservation: The Regenerative Era is Underway," brought together international experts to discuss advances in cartilage regeneration, joint preservation and emerging regenerative therapies. Regentis representatives engaged with physicians and surgeons regarding GelrinC®, the Company's CE Mark-approved, cell-free hydrogel implant designed to regenerate damaged knee cartilage.

Discussions at the Company's booth focused on GelrinC's clinical results, its ready-to-use, off-the-shelf design, and its potential to simplify cartilage repair compared with traditional surgical approaches. GelrinC is delivered in a single procedure of approximately 10 minutes, without the need for cell harvesting or laboratory processing. Based on the results of the Company's Phase II study, GelrinC demonstrated approximately 100% greater improvement in overall KOOS scores compared with historical microfracture controls at two years, with subsequent MRI analyses showing results consistent with durable, native-like cartilage regeneration.

"The strong interest and quality of our interactions with surgeons and cartilage repair specialists at ICRS were extremely encouraging," said Ehud Geller, Chief Executive Officer and Executive Chairman of Regentis Biomaterials. "We had valuable discussions with physicians who understand the limitations of existing cartilage repair procedures and are interested in new regenerative approaches that can offer meaningful benefits to patients while simplifying treatment for surgeons. We believe this level of engagement reflects growing awareness of GelrinC and its potential to help address a significant unmet need in knee cartilage repair."

Dr. Geller continued, "With GelrinC already CE Mark approved in Europe, we are focused on translating physician interest into broader clinical adoption as we advance our commercialization preparations. Our expanding network of European Centers of Excellence is an important part of that strategy, supporting surgeon education, training and clinical collaboration. At the same time, our European clinical sites are contributing to our ongoing U.S. FDA pivotal trial, providing an additional opportunity for leading surgeons to gain experience with GelrinC.

About GelrinC®

Regentis' lead product, GelrinC®, is a cell-free, off-the-shelf hydrogel implant having synchronized erosion and resorption for the treatment of painful and debilitating injuries to focal articular knee cartilage. As an innovative regenerative medical product, GelrinC® offers an unprecedented solution that gives surgeons and payers an off-the-shelf, ready to use, simple to perform, reliable, and cost-effective procedure that provides patients with a single, 10-minute procedure, faster recovery, sustained pain relief, and functional improvement for more than 5 years, based on clinical study results to date. No effective off-the-shelf, ready to use treatment for focal knee cartilage defects is currently available on the market. GelrinC® has CE Mark approval in the European Union and is now being evaluated in a pivotal U.S. Food and Drug Administration (FDA) study, which has completed over 50% enrollment.

About Regentis Biomaterials

Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing innovative tissue repair solutions that restore health and enhance quality of life. With an initial focus on orthopedic treatments, Regentis' Gelrin platform technology, based on synchronized, degradable hydrogel implants, regenerates damaged or diseased tissue including inflamed cartilage and bone. Regentis' lead product GelrinC®, is a cell-free, off-the-shelf hydrogel that is eroded and resorbed in the knee, allowing the surrounding cells to regenerate the cartilage in a controlled and synchronous process. GelrinC® aims to address a market of approximately 470,000 cases for cartilage knee repair annually in the U.S. where no off-the-shelf treatment is available.

Forward Looking Statements

This press release contains "forward-looking statements" that are subject to substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements contained in this press release may be identified by the use of words such as "anticipate," "believe," "contemplate," "could," "estimate," "expect," "intend," "seek," "may," "might," "plan," "potential," "predict," "project," "target," "aim," "should," "will" "would," or the negative of these words or other similar expressions, although not all forward-looking statements contain these words, and include statements regarding the potential benefits and performance of GelrinC; the Company's plans and expectations regarding commercialization of GelrinC in Europe; the expansion of its network of European Centers of Excellence and the expected benefits thereof; the potential for physician interest in GelrinC to result in increased awareness, clinical experience or adoption; the Company's ongoing U.S. FDA pivotal trial, including the participation of European clinical sites; and GelrinC's potential to address the market for knee cartilage repair. Forward-looking statements are based on Regentis' current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate. Factors that may affect future results and may cause these forward-looking statements to be inaccurate include, without limitation: the ability of our clinical trials to demonstrate safety and efficacy of GelrinC or any future product candidate, and other positive results; the timing and focus of our preclinical studies and clinical trials, and the reporting of data from those studies and trials; the size of the market opportunity for of GelrinC or any future product candidate, including our estimates of the number of patients who suffer from the diseases we are targeting; our ability to accurately identify demand for product candidates; the success of competing therapies that are or may become available; the beneficial characteristics, safety, efficacy and therapeutic effects of our product candidates; our ability to obtain FDA approval for of GelrinC or any future product candidate and obtain and maintain regulatory approval; our ability to obtain market acceptance of GelrinC or any future product candidate from the medical community and third-party payors; our plans relating to the further development of GelrinC or any future product candidate, including additional disease states or indications we may pursue; existing regulations and regulatory developments in the United States and other jurisdictions; our plans and ability to obtain or protect intellectual property rights, including extensions of patent terms where available and our ability to avoid infringing the intellectual property rights of others; the need to hire additional personnel and our ability to attract and retain such personnel; our estimates regarding expenses, future revenue, capital requirements and needs for additional financing; our dependence on third parties; our financial performance and our ability to repay our loans and debts; and our ability to negotiate favorable terms in any collaboration, licensing or other arrangements into which we may enter and perform our obligations under such collaborations. For a more detailed description of the risks and uncertainties affecting Regentis, reference is made to the Company's reports filed from time to time with the Securities and Exchange Commission ("SEC"), including, but not limited to, the risks detailed in the section titled "Risk Factors" in our Annual Report on Form 20-F filed with the SEC on February 24, 2026 and other public reports filed with the SEC. Forward-looking statements contained in this announcement are made as of this date, and Regentis undertakes no duty to update such information except as required under applicable law.

Contact:
[email protected]

SOURCE: Regentis Biomaterials Ltd

-

Company Pays Dividend for 201st Consecutive Quarter

MIAMI--(BUSINESS WIRE)--The Board of Directors of Ryder System, Inc. (NYSE: R) declared a regular quarterly cash dividend of $1.01 per share of common stock to be paid on December 18, 2026 to shareholders of record on November 23, 2026.

This is Ryder’s 201st consecutive quarterly cash dividend – marking 50 years of uninterrupted dividend payments.

About Ryder System, Inc.

Ryder System, Inc. (NYSE: R) is a nearly $13 billion leading provider of outsourced logistics and transportation services throughout the United States, Canada, and Mexico. Ryder offers supply chain, dedicated transportation, and fleet management solutions that integrate every step of the supply chain port‑to‑door, including cross-border logistics, fleet and transportation management, warehousing and distribution, and final delivery to customers’ doorsteps. Ryder’s broad portfolio of services encompasses managed transportation, freight brokerage, dedicated contract carriage with professional drivers, full‑service fleet leasing and maintenance, commercial truck rental, automation and robotics, digital technologies, contract manufacturing and packaging, omnichannel retail fulfillment including e-commerce and last-mile delivery, and used vehicle sales. Serving more than 20 industries, Ryder manages approximately 240,000 commercial vehicles, operates nearly 800 maintenance locations, and runs approximately 320 warehouses totaling more than 100 million square feet. Ryder is consistently recognized for technology‑driven innovation and industry‑leading practices in safety, health, security, talent acquisition, and environmental management, and was most recently named to Fortune’s “America’s Most Innovative Companies” list. www.ryder.com

Note Regarding Forward-Looking Statements: Certain statements and information included in this news release are “forward-looking statements” within the meaning of the Federal Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on our current plans and expectations and are subject to risks, uncertainties and assumptions. Accordingly, these forward-looking statements should be evaluated with consideration given to the many risks and uncertainties that could cause actual results and events to differ materially from those in the forward-looking statements including those risks set forth in our periodic filings with the Securities and Exchange Commission. New risks emerge from time to time. It is not possible for management to predict all such risk factors or to assess the impact of such risks on our business. Accordingly, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

ryder-financial

More News From Ryder System, Inc.

Back to Newsroom

Vancouver, British Columbia and Temecula, California--(Newsfile Corp. - October 9, 2026) - Jackpot Digital Inc. (TSXV: JJ) (OTCQB: JPOTF) (Frankfurt Stock Exchange: LVH3) ("Jackpot Digital" or the "Company"), the world's leading manufacturer of dealerless multiplayer electronic poker tables, and Pechanga Resort Casino, one of North America's largest and most respected Tribal gaming destinations, are pleased to jointly announce that eight (8) Jackpot Blitz® electronic poker tables are now open for play at Pechanga Resort Casino, located just outside of Temecula, California.

Jackpot Digital and Pechanga Resort Casino Executive and Board Members Cut the Ribbon Marking the Opening of 8 New Digital Poker Games at Pechanga Resort Casino Outside Temecula, Calif. 

CLICK HERE for high resolution, downloadable photos.

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10595/318175_45641dd74470aadd_003full.jpg

Pechanga Development Corporation Board Members and Pechanga Resort Casino executives joined Jackpot Digital's leadership teams in cutting the ceremonial ribbon to usher in the eight new electronic tables. Pechanga Resort Casino's Vice President of Table Games, Paul Mollo, also helped give away prizes such as EasyPlay and apparel to Pechanga guests eager to find out about the excitement.

The launch marks an important milestone for both companies. Guests will find the dealerless and fast-action poker games in the Table Games section of the resort/casino, near the casino floor escalator. This launch also represents Jackpot Digital's largest single-property deployment to date.

With the launch of Jackpot Blitz®, Pechanga is bringing the social energy and excitement of digital poker to its casino floor in a new format designed to deliver a fast, engaging experience for both longtime poker players and a new generation of guests.

"We're excited to bring this energized and social experience to Pechanga Resort Casino with a modern dealerless format. We think guests new to the game, and those who have loved it for years will really enjoy Jackpot Blitz® and the benefits it brings to poker play," said Paul Mollo, Vice President of Table Games at Pechanga Resort Casino.

Jackpot Blitz® combines the social, face-to-face experience with the speed, consistency and convenience of digital technology. Players remain together at a shared table while the system manages the game electronically. Each table features an immersive, 75-inch touchscreen interface. It also showcases Jackpot Digital's proprietary card-bending technology, which mechanically bends and reveals each player's cards at the table in real time, recreating the familiar experience of checking a physical poker hand. The result is a modern poker experience designed to deliver consistent gameplay and efficient table operation.

To see Jackpot Blitz® in action, watch this two-minute video featuring Jackpot Blitz® Brand Ambassador Jimmy Johnson, Pro Football Hall of Fame member and two-time Super Bowl-winning coach, as he walks through gameplay on the table:

Cannot view this video? Visit:
https://www.youtube.com/watch?v=Ok313WD5NpI

"Pechanga Resort Casino has one of the most impressive and well-visited casino floors in the country and we eagerly await how their guests will enjoy the new, immersive poker tables," said Jake Kalpakian, President and CEO of Jackpot Digital. "Seeing eight Jackpot Blitz® tables go live at a property of Pechanga's history and reputation is a proud moment for our team. This launch is also an important milestone for Jackpot Digital, demonstrating the scalability of our dealerless poker platform."

What Players Can Expect Today

The eight Jackpot Blitz® tables are open now on the Pechanga Resort Casino gaming floor. Pechanga's poker area will feature a range of poker action and launch promotions, including cash game, tournaments, giveaways and bad beat jackpots, with additional promotions to be introduced regularly.

Players are encouraged to visit Pechanga.com/play or follow Pechanga on Facebook, Instagram and X for the latest tournament schedules, promotions and bad beat jackpot totals.

About Jackpot Blitz®

Jackpot Blitz® is Jackpot Digital's state-of-the-art, fully automated dealerless poker table. By removing the need for a live dealer, Jackpot Blitz® delivers faster gameplay, more hands per hour, reduced operating costs, maximized table uptime, and an engaging poker experience for casual and experienced players alike - all while preserving the social, face-to-face energy that makes live poker unique.

About Jackpot Digital Inc.

Jackpot Digital Inc. is the world's leading manufacturer of dealerless multiplayer electronic poker tables. The Company's flagship product, Jackpot Blitz®, is designed to help casino operators optimize gaming floor economics, reduce labor costs, and drive incremental revenue, while giving players a faster, consistent and engaging way to play poker. Jackpot Digital continues to expand its footprint across major U.S. casino markets.

About Pechanga Resort Casino

Pechanga Resort Casino offers one of the largest and most expansive resort/casino experiences anywhere in the United States. Voted the best resort/casino in the United States by readers of Condé Nast Traveler and rated a Four Diamond property by AAA since 2002, Pechanga Resort Casino provides an unparalleled getaway, whether for the day or for an extended luxury stay. Offering 5,500 of the hottest slots, table games, world-class entertainment, 1,100 hotel rooms, dining, spa and championship golf at Journey at Pechanga, Pechanga Resort Casino features an unmatched destination in California. Pechanga Resort Casino is owned and operated by the Pechanga Band of Indians. For more information, call toll free 1-888-PECHANGA or visit www.Pechanga.com. Follow Pechanga Resort Casino on Facebook X and Instagram @PechangaCasino. Pechanga Resort Casino is open 24 hours. Guests must be 21 and older to enter the casino.

Trading in the securities of the Company should be considered speculative.

The TSX Venture Exchange has neither approved nor disapproved the contents of this news release.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

Certain statements contained herein are "forward-looking". Forward-looking statements may include, among others, statements regarding Jackpot's future plans, the obtaining of customary regulatory approvals, projected or proposed financings, costs, objectives, economic or technical performance, or the assumptions underlying any of the foregoing. In this News Release, words such as "may", "would", "could", "will", "likely", "enable", "feel", "seek", "project", "predict", "potential", "should", "might", "objective", "believe", "expects", "propose", "anticipate", "intend", "plan", "plans" "estimate", "in due course" and similar words are used to identify forward-looking statements. Forward-looking statements are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those expressed or implied. Although management believes that the expectations reflected in such forward-looking statements are based on reasonable assumptions, projections and estimations, there can be no assurance that these assumptions, projections or estimations are accurate. Readers, shareholders and investors are therefore cautioned not to place reliance on any forward-looking statements as the plans, assumptions, intentions or expectations upon which they are based might not occur.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/318175

Source: Jackpot Digital Inc.

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, growth, and momentum to find strong companies for our readers.

Looking at the history of these trends, perhaps none is more beloved than value investing. This strategy simply looks to identify companies that are being undervalued by the broader market. Value investors use tried-and-true metrics and fundamental analysis to find companies that they believe are undervalued at their current share price levels.

Luckily, Zacks has developed its own Style Scores system in an effort to find stocks with specific traits. Value investors will be interested in the system's "Value" category. Stocks with both "A" grades in the Value category and high Zacks Ranks are among the strongest value stocks on the market right now.

Ryder System (R - Free Report) is a stock many investors are watching right now. R is currently sporting a Zacks Rank #2 (Buy) and an A for Value. The stock is trading with a P/E ratio of 12.74, which compares to its industry's average of 14.59. Over the past year, R's Forward P/E has been as high as 13.18 and as low as 9.22, with a median of 11.32.

Another valuation metric that we should highlight is R's P/B ratio of 2.44. The P/B ratio pits a stock's market value against its book value, which is defined as total assets minus total liabilities. This stock's P/B looks attractive against its industry's average P/B of 4.04. Over the past year, R's P/B has been as high as 2.52 and as low as 1.79, with a median of 2.16.

Value investors also use the P/S ratio. The P/S ratio is calculated as price divided by sales. This is a preferred metric because revenue can't really be manipulated, so sales are often a truer performance indicator. R has a P/S ratio of 0.69. This compares to its industry's average P/S of 0.99.

These figures are just a handful of the metrics value investors tend to look at, but they help show that Ryder System is likely being undervalued right now. Considering this, as well as the strength of its earnings outlook, R feels like a great value stock at the moment.

Hertz just snapped a nine-session losing streak off record lows while the broader transportation sector slides in the opposite direction, and traders are left scrambling to explain a bounce that has no confirmed catalyst behind it.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Beaten-down rental stocks are bouncing while the wider transportation sector slips, and Hertz Global Holdings (NASDAQ:HTZ) is leading the rebound from the deepest hole in the group. Hertz stock is at $2.08, up 16% in afternoon trading, a sharp reversal off a record low, according to Stocktwits. Even after the jump, Hertz shares remain far below their starting level for the year.

Checking in on the peers, shares of Avis Budget Group (NASDAQ:CAR | CAR Price Prediction) are at $113.47, up 5%, as the rival car renter joins the rally. Ryder System (NYSE:R) stock is at $237.02, up 0.5%, a modest advance from the truck lessor that trails both car-rental names.

The rental bounce stands apart from its sector, with the iShares U.S. Transportation ETF (CBOE:IYT) down 0.4%. The iShares Russell 2000 ETF (NYSEARCA:IWM), a useful small-cap gauge for Hertz, is down 0.6%. Hertz has issued no announcement to account for the move, and all three rental names are climbing while both funds slip.

Record Short Interest Frames the Hertz Rebound Hertz stock fell for nine consecutive sessions into record lows before the rebound, a losing streak. Short interest in Hertz shares also climbed to the highest level on record during that decline. This rebound is consistent with short covering. Traders may be buying back borrowed Hertz shares to close their short positions, though no available data confirms that short sellers drove the move.

The next scheduled update comes soon, as Hertz has stated it plans to report its third-quarter 2026 results on November 5. That report could show whether the rental business at Hertz is steadying after a hard year, while until then positioning may drive much of the action in Hertz stock and a crowded short side can amplify swings in both directions.

Year-to-Date Gap Separates Hertz From Ryder Measured from January, the gap is far wider: Hertz shares are down 60% year to date (YTD), and a 14% bounce barely reduces that deficit. Avis Budget Group stock is down 12% YTD, a far smaller loss, while Ryder stock is up 25% YTD. That ranking stays intact after the rally, with Hertz still climbing from the lowest base of the three.

Hertz runs the Hertz, Dollar, Thrifty and Firefly brands. They span roughly 11,000 locations in 160 countries, according to Stocktwits, and like Avis Budget Group depends on travel demand, the shared exposure behind both renters’ moves.

Travel exposure links the two car renters, and Avis Budget Group shares are tracking Hertz higher by a smaller margin, with the narrower YTD loss in Avis stock suggesting the market has punished the company far less than Hertz.

What to Watch Next The optimistic outlook for Hertz depends on its rental business steadying before its balance sheet forces the issue. A fleet owner like Hertz at this share price has little margin for a weak quarter, which raises the stakes for the company’s upcoming report. Shareholders can watch for whether Hertz’s third-quarter results show that stabilization taking hold.

Ryder stock carries the steadiest profile of the three, while Avis stock sits between Ryder and Hertz shares on YTD performance. Traders could watch whether the rally survives the weakness in transportation and small-cap funds.

Anyone exposed to the name should adjust their holdings carefully given the 60% YTD decline in Hertz stock and the lack of a confirmed driver behind the bounce. Ryder’s freight exposure and the smaller YTD loss in Avis stock support a prudent policy of keeping your positions in either name moderate.

Contact [email protected] for any questions or corrections.

NEOS Investments, an asset management firm comprised of leaders and pioneers in the options-based ETF space, announces September monthly distribution amounts for their suite of ETFs that pursue monthly income and tax efficiency across core portfolio exposures.

September 2026 Distribution Information, based on each ETFs Ex-Dividend Date:

Distribution

Rate*

Amount /

Share (%)

Amount /

Share ($)

Ex-Dividend Date

30-Day SEC Yield**

Boosted Bitcoin High Income ETF (XBCI)

40.74%

3.40%

$1.2488

09/02/2026

1.12%

Ethereum High Income ETF (NEHI)

34.38%

2.87%

$0.8721

09/16/2026

1.13%

Bitcoin High Income ETF (BTCI)

28.00%

2.33%

$0.7184

09/16/2026

1.35%

Boosted Nasdaq-100 High Income ETF (XQQI)

21.04%

1.75%

$0.8403

09/02/2026

-0.32%

Boosted S&P 500 High Income ETF (XSPI)

17.08%

1.42%

$0.7025

09/02/2026

0.18%

Russell 2000 High Income ETF (IWMI)

14.60%

1.22%

$0.6075

09/16/2026

0.52%

MLP & Energy Infrastructure High Income ETF (MLPI)

14.34%

1.20%

$0.6276

09/16/2026

3.47%

Nasdaq-100 High Income ETF (QQQI)

14.28%

1.19%

$0.6339

09/16/2026

-0.05%

S&P 500 High Income ETF (SPYI)

12.21%

1.02%

$0.5338

09/16/2026

0.46%

Gold High Income ETF (IAUI)

12.15%

1.01%

$0.5011

09/16/2026

1.87%

Real Estate High Income ETF (IYRI)

11.00%

0.92%

$0.4289

09/16/2026

3.05%

MSCI EAFE High Income ETF (NIHI)

9.74%

0.81%

$0.4168

09/16/2026

2.73%

Nasdaq-100 Hedged Equity Income ETF (QQQH)

9.06%

0.76%

$0.4190

09/23/2026

-0.01%

Enhanced Income Credit Select ETF (HYBI)

8.11%

0.68%

$0.3277

09/09/2026

6.13%

S&P 500 Hedged Equity Income ETF (SPYH)

7.89%

0.66%

$0.3710

09/23/2026

0.50%

Enhanced Income 20+ Year Treasury Bond ETF (TLTI)

6.31%

0.53%

$0.2270

09/09/2026

4.71%

Enhanced Income Aggregate Bond ETF (BNDI)

5.81%

0.48%

$0.2219

09/09/2026

3.53%

Long/Short Equity Income ETF (NLSI)

5.39%

0.45%

$0.2551

09/23/2026

-0.37%

Enhanced Income 1-3 Month T-Bill ETF (CSHI)

5.00%

0.42%

$0.2066

09/09/2026

3.30%

Average Annual Returns (%) as of Most Recent Quarter-End (06/30/2026)

Fund Name

Inception

Date

Ticker

Type

1 Year

5

Year

10

Year

Inception

NEOS Enhanced Income Aggregate Bond ETF

8/29/2022

BNDI

MKT

5.27

--

--

4.08

NEOS Enhanced Income Aggregate Bond ETF

8/29/2022

BNDI

NAV

5.57

--

--

4.09

NEOS Bitcoin High Income ETF

10/16/2024

BTCI

MKT

-40.95

--

--

-7.50

NEOS Bitcoin High Income ETF

10/16/2024

BTCI

NAV

-40.91

--

--

-7.65

NEOS Enhanced Income 1-3 Month T-Bill ETF

8/29/2022

CSHI

MKT

5.16

--

--

5.48

NEOS Enhanced Income 1-3 Month T-Bill ETF

8/29/2022

CSHI

NAV

5.10

--

--

5.47

NEOS Enhanced Cr Select ETF

9/30/2014

HYBI

MKT

5.92

3.46

4.35

4.17

NEOS Enhanced Cr Select ETF

9/30/2014

HYBI

NAV

5.87

3.47

4.36

4.18

NEOS Gold High Income ETF

6/4/2025

IAUI

MKT

12.04

--

--

10.12

NEOS Gold High Income ETF

6/4/2025

IAUI

NAV

12.01

--

--

10.01

NEOS Russell 2000 High Income ETF

6/24/2024

IWMI

MKT

35.91

--

--

20.07

NEOS Russell 2000 High Income ETF

6/24/2024

IWMI

NAV

36.26

--

--

20.18

NEOS Real Estate High Income ETF

1/14/2025

IYRI

MKT

9.54

--

--

10.82

NEOS Real Estate High Income ETF

1/14/2025

IYRI

NAV

9.68

--

--

10.77

NEOS MLP & Energy Infrastructure High Income ETF

12/17/2025

MLPI

MKT

--

--

--

19.96

NEOS MLP & Energy Infrastructure High Income ETF

12/17/2025

MLPI

NAV

--

--

--

19.68

NEOS Ethereum High Income ETF

12/2/2025

NEHI

MKT

--

--

--

-42.40

NEOS Ethereum High Income ETF

12/2/2025

NEHI

NAV

--

--

--

-42.87

NEOS MSCI EAFE High Income ETF

9/16/2025

NIHI

MKT

--

--

--

12.46

NEOS MSCI EAFE High Income ETF

9/16/2025

NIHI

NAV

--

--

--

12.41

NEOS Long/Short Equity Income ETF

12/9/2025

NLSI

MKT

--

--

--

5.30

NEOS Long/Short Equity Income ETF

12/9/2025

NLSI

NAV

--

--

--

5.28

NEOS NASDAQ-100 Hedged Equity Income ETF

12/19/2019

QQQH

MKT

16.78

8.40

--

10.39

NEOS NASDAQ-100 Hedged Equity Income ETF

12/19/2019

QQQH

NAV

16.85

8.47

--

10.42

NEOS Nasdaq 100 High Income ETF

1/29/2024

QQQI

MKT

25.70

--

--

21.50

NEOS Nasdaq 100 High Income ETF

1/29/2024

QQQI

NAV

25.99

--

--

21.63

NEOS S&P 500 Hedged Equity Income ETF

4/2/2025

SPYH

MKT

14.97

--

--

18.00

NEOS S&P 500 Hedged Equity Income ETF

4/2/2025

SPYH

NAV

14.97

--

--

17.95

NEOS S&P 500 (R) High Income ETF

8/29/2022

SPYI

MKT

18.97

--

--

14.81

NEOS S&P 500 (R) High Income ETF

8/29/2022

SPYI

NAV

19.02

--

--

14.86

NEOS Enhanced Income 20+ Year Treasury Bond ETF

12/10/2024

TLTI

MKT

3.89

--

--

0.58

NEOS Enhanced Income 20+ Year Treasury Bond ETF

12/10/2024

TLTI

NAV

4.01

--

--

0.42

NEOS Boosted Bitcoin High Income ETF

2/2/2026

XBCI

MKT

--

--

--

-29.38

NEOS Boosted Bitcoin High Income ETF

2/2/2026

XBCI

NAV

--

--

--

-30.35

NEOS Boosted Nasdaq-100 High Income ETF

2/2/2026

XQQI

MKT

--

--

--

15.94

NEOS Boosted Nasdaq-100 High Income ETF

2/2/2026

XQQI

NAV

--

--

--

15.62

NEOS Boosted S&P 500 High Income ETF

2/2/2026

XSPI

MKT

--

--

--

6.73

NEOS Boosted S&P 500 High Income ETF

2/2/2026

XSPI

NAV

--

--

--

6.48

About NEOS Investments: Founded in 2022, NEOS Investments offers ETFs that aim to deliver the next evolution of options strategies, where seeking income is the outcome. Built on decades of research and experience, NEOS ETFs aim to empower investors with portfolio building blocks that provide monthly income, tax efficiency, and diversification through data-driven options-based ETFs.

The performance data quoted above represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor’s shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted above. Inception performance for funds with less than one year of history reflect cumulative returns. Standardized performance current to the most recent month-end and quarter-end can be obtained by visiting any of the corresponding ETF funds pages by clicking on their ticker: SPYI | QQQI | IWMI | QQQH | BTCI | HYBI | BNDI | CSHI| TLTI | IYRI | SPYH| IAUI| NIHI | NEHI | NLSI | MLPI | XSPI | XQQI | XBCI or calling 866.498.5677.

ETF Management Fees: XSPI, XQQI, XSPI, BTCI, NEHI, NLSI = 0.98% | IAUI = 0.78% | SPYI, QQQI, SPYH, IWMI, MLPI, NIHI, QQQH, HYBI, IYRI = 0.68% | BNDI, TLTI = 0.58% | CSHI = 0.38%

The Advisor has contractually agreed to keep the net expenses of BNDI from exceeding 0.58% of the Fund's average daily net assets through May 1, 2027 subject to approval of the agreement by the Board. Without the fee waiver the Fund expenses would be 0.61%. Additionally, the Advisor has contractually agreed to keep the net expenses of IWMI from exceeding 0.68% of the Fund's average daily net assets through May 1, 2027 subject to approval of the agreement by the Board. Without the fee waiver the Fund expenses would be 0.76%. Additionally, the Advisor has contractually agreed to keep the net expenses of HYBI from exceeding 0.68% of the Fund's average daily net assets through May 1, 2027 subject to approval of the agreement by the Board. Without the fee waiver the Fund expenses would be 0.72%. Additionally, the Advisor has contractually agreed to keep the net expenses of NIHI from exceeding 0.68% of the Fund's average daily net assets through May 1, 2027 subject to approval of the agreement by the Board. Without the fee waiver the Fund expenses would be 0.75%. The total annual fund operating expenses of NLSI are 2.89%, comprised of a 0.98% management fee and 1.91% of other expenses including dividend, interest and brokerage expenses on short positions based on estimated amounts for the Fund's current fiscal year. The total annual fund operating expenses of IAUI are 0.79%, comprised of a 0.78% management fee and 0.01% of acquired fund fees and expenses, which are the indirect costs of investing in other investment companies (including money market funds). The total annual fund operating expenses of BTCI are 0.99%, comprised of a 0.98% management fee and 0.01% of acquired fund fees and expenses, which are the indirect costs of investing in other investment companies (including money market funds).

*The Distribution Rate is the annual yield an investor would receive if the most recently declared distribution, which includes option income, remained the same going forward. The Distribution Rate is calculated by multiplying an ETF’s Distribution per Share by twelve (12), and dividing the resulting amount by the ETF’s most recent ex-date NAV. The Distribution Rate represents a single distribution from the ETF and does not represent its total return. Distributions are not guaranteed.

Distributions made by the Funds have been classified as a return of capital and may be comprised of option premiums, dividends, capital gains, and interest payments. Please see the 19a-1 notices for an estimated breakdown of monthly distributions on each Fund's page.

Distributions in excess of the Fund’s current and accumulated earnings and profits are treated as a tax-free return of your investment to the extent of your basis in the Shares, and generally as capital gain thereafter. A return of capital, which for tax purposes is treated as a return of your investment, reduces your basis in Shares, thus reducing any loss or increasing any gain on a subsequent taxable disposition of Shares. A distribution will reduce the Fund’s NAV per Share and may be taxable to you as ordinary income or capital gain even though, from an economic standpoint, the distribution may constitute a return of capital.

**30-day SEC Yield is calculation based on a formula mandated by the Securities and Exchange Commission (SEC) that calculates a fund's hypothetical annualized income, as a percentage of its assets. A security's income, for the purposes of this calculation, is based on the current market yield to maturity (in the case of bonds) or projected dividend yield (for stocks) of the fund's holdings over a trailing 30-day period. This hypothetical income will differ (at times, significantly) from the fund's actual experience; as a result, income distributions from the fund may be higher or lower than implied by the SEC yield. It is important to note that 30-Day SEC Yield does not include income received from option selling. The data reflects the most recent month-end (08/31/2026). The Unsubsidized 30-day SEC Yield represents what a fund’s 30-day SEC yield would be had no fee waiver been in place over the reporting period. BNDI = 3.50%, HYBI = 6.10%, IWMI = 0.46%, NIHI = 2.66%.

Investors should carefully consider the investment objectives, risks, charges and expenses of Exchange Traded Funds (ETFs) before investing. To obtain an ETF's prospectus containing this and other important information, please call (866) 498-5677 or view/download a prospectus by clicking on the corresponding ETF ticker: SPYI | QQQI | IWMI | QQQH | BTCI | HYBI | BNDI | CSHI| TLTI| IYRI | SPYH| IAUI| NIHI | NEHI | NLSI | MLPI | XSPI | XQQI | XBCI. Please read the prospectus carefully before you invest.

An investment in NEOS ETFs involves risk, including possible loss of principal. The equity securities purchased by the Funds may involve large price swings and potential for loss. Investments in smaller companies typically exhibit higher volatility. Investors in the ETFs should be willing to accept a high degree of volatility in the price of fund shares and the possibility of significant losses.

The use of derivative instruments involves risks different from, or possibly greater than, the risks associated with investing directly in securities and other traditional investments. These risks include (i) the risk that the counterparty to a derivative transaction may not fulfill its contractual obligations; (ii) risk of mispricing or improper valuation; and (iii) the risk that changes in the value of the derivative may not correlate perfectly with the underlying asset, rate or index. Derivative prices are highly volatile and may fluctuate substantially during a short period of time. The use of leverage by the Fund, such as borrowing money to purchase securities or the use of options, will cause the Fund to incur additional expenses and magnify the Fund’s gains or losses. The earnings and prospects of small and medium-sized companies are more volatile than larger companies and may experience higher failure rates than larger companies. Small and medium sized companies normally have a lower trading volume than larger companies, which may tend to make their market price fall more disproportionately than larger companies in response to selling pressures and may have limited markets, product lines, or financial resources and lack management experience. The funds are new with a limited operating history.

The information on this website does not constitute investment advice or a recommendation of any products, strategies, or services. Investors should consult with a financial professional regarding their individual circumstances before making investment decisions. NEOS Investments or its affiliates, nor Foreside Fund Services, LLC, or its affiliates accept any responsibility for loss arising from the use of the information contained herein.

NEOS ETFs are distributed by Foreside Fund Services, LLC.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260930747947/en/

Disclosures I/we have no positions in any stocks mentioned, and have no plans to buy any new positions in the stocks mentioned within the next 72 hours.

Click for the complete disclosure

Launch introduces ondansetron 4 mg and 8 mg tablets for nausea and vomiting associated with chemotherapy, radiation therapy and surgeryGlobal ondansetron market projected to reach $2.98 billion by 2034, up from $1.82 billion in 2025, according to DataInteloCommercial rollout supported by Nora Pharma's established Canadian distribution network, further expanding Sunshine Biopharma's generic prescription drug portfolio FORT LAUDERDALE, FL / ACCESS Newswire / September 24, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company specializing in generic and specialty prescription medications including drugs in the areas of oncology and antivirals, is pleased to announce that it has launched generic Ondansetron tablets of 4mg and 8mg in the Canadian market. Ondansetron is the generic equivalent of the brand name, Zofran®.

Ondansetron is widely prescribed for nausea and vomiting caused by cancer chemotherapy, radiation therapy, and surgery. Ondansetron is a prescription serotonin 5-HT3 receptor antagonist. It works by blocking the actions of chemicals in the body that trigger nausea and vomiting. By offering two strengths (4mg and 8mg) and film-coated tablets, healthcare providers can better tailor the treatment to individual patient needs and physical condition.

According to DataIntelo, the global Ondansetron market was valued at $1.82 billion in 2025 and is projected to reach $2.98 billion by 2034, expanding at a compound annual growth rate (CAGR) of 5.6%. The rapid growth is driven by escalating cancer diagnoses worldwide, increased number of surgical procedures, and broad-based adoption of Ondansetron across multiple clinical indications. The global Nausea Medicine Market is growing steadily, fueled by increasing cases of nausea related to chemotherapy, motion sickness, gastrointestinal issues, and pregnancy. According to IQVIA Pharmafocus 2028, the Canadian pharmaceutical market accounts for approximately 2.1% of the global pharmaceutical market and ranks as the 6th largest worldwide.

Sunshine Biopharma has established a robust distribution network across Canada through its wholly owned Canadian subsidiary, Nora Pharma Inc. The addition of Ondansetron to our portfolio of drugs represents a strategic expansion for the Company into the area of nausea and vomiting caused by cancer therapy.

"Launching Ondansetron oral tablets represents another decisive step in scaling Sunshine Biopharma's generics business," said Dr. Steve Slilaty, CEO. "This product enhances our competitive position and reflects our ongoing commitment to broadening access to dependable, much needed pharmaceuticals."

About Sunshine Biopharma Inc.

Sunshine Biopharma currently has 61 generic prescription drugs on the market in Canada and approximately 11 additional drugs scheduled to be launched in the remainder of 2026. In addition, Sunshine Biopharma is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA, an mRNA-Lipid Nanoparticle targeted for liver cancer, and (ii) PLpro protease inhibitor, a small molecule for treatment of SARS Coronavirus infections. For more information, please visit: www.sunshinebiopharma.com.

All registered trademarks are the property of their respective owners.

Safe Harbor Forward-Looking Statements

This press release contains forward-looking statements which are based on current expectations, forecasts, and assumptions of Sunshine Biopharma Inc. (the "Company") that involve risks as well as uncertainties that could cause actual outcomes and results to differ materially from those anticipated or expected. These statements appear in this release and include all statements that are not statements of historical fact regarding the intent, belief or current expectations of the Company, including statements related to the Company's drug development activities, financial performance, and future growth. These risks and uncertainties are further described in filings and reports by the Company with the U.S. Securities and Exchange Commission (SEC). Actual results and the timing of certain events could differ materially from those projected in or contemplated by the forward-looking statements due to a number of factors detailed from time to time in the Company's filings with the SEC. Reference is hereby made to cautionary statements and risk factors set forth in the Company's most recent SEC filings.

For more information, please contact:

Camille Sebaaly, CFO
Direct Line: 514-814-0464
[email protected]

SOURCE: Sunshine Biopharma Inc.

Toronto, Ontario--(Newsfile Corp. - September 23, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE: 9DY) (OTCQB: TMPTF) ("TempraMed" or the "Company"), a medical-technology innovator transforming how temperature-sensitive medications are stored and managed, is pleased to announce it has entered into a distribution agreement dated August 25, 2026 (the "Distribution Agreement") with CenterWell Pharmacy, Inc. ("CenterWell") the pharmacy services brand of Humana Inc, a major U.S. health insurer.

About TempraMed Technologies Ltd.

TempraMed Technologies Ltd. is a global medical-device company with a portfolio of innovative, temperature-controlled medication-storage solutions. Founded with the mission to safeguard the effectiveness of life-saving medications, TempraMed develops patented, FDA-registered thermal-insulation devices that operate continuously without batteries or external power. Its commercial product portfolio includes VIVI Cap™, VIVI Cap Smart™, VIVI Epi™, and VIVI Med™. TempraMed enables patients and healthcare providers to confidently manage temperature-sensitive medications anywhere, anytime.

Investors interested in learning more about TempraMed are encouraged to contact the Company at:

Cautionary Statements

THE CANADIAN SECURITIES EXCHANGE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE, NOR HAS OR DOES THE CSE'S REGULATION SERVICES PROVIDER.

This press release contains "forward-looking information" and "forward-looking statements" within the meaning of applicable Canadian securities legislation (collectively, "forward-looking statements"). Forward-looking statements may be identified by words such as "anticipate," "believe," "expect," "intend," "may," "plan," "potential," "should," "strategy," "will" and similar expressions, or statements concerning events or conditions that may occur in the future.

Forward-looking statements in this press release include, without limitation, statements regarding: the anticipated distribution of VIVI Cap® and VIVI Epi® by CenterWell Pharmacy, Inc. under the Distribution Agreement; the expected commercial benefits of the Distribution Agreement to the Company; the timing, volume and value of any orders that may be placed under the Distribution Agreement and the Company's ability to fulfill them; adoption of the Company's products by patients and healthcare providers in the United States; the continuation of the Distribution Agreement, which may be terminated by either party on 60 days' prior written notice; and the Company's ability to expand its commercial presence in the United States.

Forward-looking statements are based on the opinions, expectations and assumptions of management as of the date of this press release, including assumptions regarding: performance by CenterWell Pharmacy, Inc. of its obligations under the Distribution Agreement; the Company's ability to manufacture and supply its products in the quantities and on the timelines that may be required; the Company's ability to maintain applicable regulatory registrations for its products in the United States; continued demand for temperature-protection solutions for temperature-sensitive medications; and the absence of material adverse changes in general economic, regulatory or market conditions.

Forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause actual results to differ materially from those expressed or implied, including: [the Distribution Agreement does not contain minimum purchase commitments and] there is no assurance that any orders will be placed, or that any revenue will be generated, under the Distribution Agreement; the risk that the Distribution Agreement may be terminated by either party on short notice; the Company's reliance on CenterWell Pharmacy, Inc. for distribution of its products in the channel contemplated by the Distribution Agreement; manufacturing, supply-chain and quality-control risks; changes in the regulatory environment applicable to medical devices in the United States; competitive developments; market acceptance of the Company's products; general economic conditions; geopolitical risks; and other risks described in the Company's public filings available on SEDAR+.

Except as required by applicable securities laws, the Company undertakes no obligation to update or revise publicly any forward-looking statements.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/315436

Source: TempraMed Technologies Ltd.

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

MIAMI--(BUSINESS WIRE)--Ryder System, Inc. (NYSE: R) expects to issue its third quarter 2026 results at approximately 7:00 a.m. Eastern Time on Thursday, October 22, 2026. The company will also host a conference call at 11 a.m. Eastern Time on the same day. The call will be webcast live and a replay will be available. Details for the call include: When: Thursday, October 22, 2026, from 11:00 a.m. to 12:00 p.m. Eastern Time   How: Live webcast: Ryder - 3Q 2026 Ryder System Inc. Earnings Conferen.

Amazon.ca Becomes Fourth Major North American Retailer Selling IFTNA's Tech-Enhanced Scrubs Clinically-Validated Scrubs Now Available for Healthcare Practitioners Across Canada MARKHAM, ON / ACCESS Newswire / September 21, 2026 / iFabric Corp. ("iFabric" or the "Company") (TSX:IFA)(OTCQX:IFABF) announces that its wholly-owned subsidiary, Intelligent Fabric Technologies (North America) Inc. ("IFTNA"), is launching Doctor's Choice® clinically-proven scrubs on Amazon Canada (Amazon.ca), one of the largest and most widely used e-commerce platforms in the country. The launch makes Doctor's Choice® scrubs available to healthcare practitioners across Canada, delivered directly to their doors.

Constellation Brings Dôr's Retail Intelligence Architecture to Healthcare

Connects Clinical, Scheduling, Call-Center and Staffing Data to Predict Care Needs, Optimize Provider Capacity and Improve Patient Access

DALLAS, TX / ACCESS Newswire / September 17, 2026 / AIAI Holdings Corporation (NASDAQ:AIAI) ("Ai2" or the "Company"), an AI-enabled diversified holding company utilizing Transformational AI (TAI) to enhance portfolio performance announced today that its portfolio company, Constellation Network, through Dôr Technologies, has launched Dôr Patient Journey, a new healthcare intelligence platform. Developed in collaboration with Proactive MD, the platform is actively deployed within Proactive MD's care environment.

Patient Journey represents the first healthcare extension of Dôr's recently launched Retail Intelligence platform, applying the same underlying intelligence architecture, connecting physical-world activity with existing operational systems and Transformational AI to the delivery of care. In retail, Dôr connects physical customer traffic with point-of-sale, labor, weather, marketing and other operational data to understand why performance changed and what an operator should do next. In healthcare, Patient Journey connects physical care delivery with clinical, scheduling, call-center, staffing and other authorized operational data to understand what care actually requires and how healthcare organizations can respond more intelligently.

Patient Journey is designed to connect with any authorized API-accessible operating system, including electronic health records and practice management, scheduling, call-center and telephony, workforce and staffing platforms. Rather than requiring healthcare organizations to replace the systems they already use, Patient Journey creates an intelligence layer across them while adding an independent understanding of what physically occurred throughout the delivery of care.

Dôr's privacy-first sensing technology captures no patient identity. Its anonymous sensors record no images, video, audio or biometric identifiers and require nothing from the patients whose care they help measure. The result is a healthcare intelligence platform designed to connect what was scheduled, documented, billed and recorded with what actually happened in the physical world.

"Retail Intelligence proved this architecture in physical commerce. Patient Journey proves it transfers into an environment where minutes, staffing and physical capacity carry both economic and human consequences," said Todd Furniss, Chief Executive Officer and Co-founder of AIAI Holdings Corporation. "That is the thesis AIAI was built on: one Transformational AI architecture, applied to the real-world operations of industry after industry."

Proactive MD operates more than 80 Health Centers nationwide and is integrating hundreds of additional practices through the Proactive MD Alliance. Proactive MD's Advanced Primary Care environment represents the first healthcare deployment announced. The same underlying model of measure, connect, reconcile, explain, predict and optimize is designed to extend across primary and specialty care, imaging, infusion, rehabilitation, urgent care, ambulatory surgery centers and multisite healthcare networks.

"The opportunity is much bigger than measuring how long a patient waits in a room. If we can understand what patients actually need, what that care truly requires, and how that demand moves through the organization, we can build schedules and staffing around the real work instead of a standardized block," said Jeremy VanderKnyff, Chief Product Officer of Proactive MD. "That changes the experience for patients and for the care teams delivering it."

Dôr's Patient Journey is designed to help healthcare organizations:

Identify delays and bottlenecks as patients move through different stages of care.Understand how appointment types vary in the time, rooms and staff they require.Align schedules and staffing with observed care requirements and available capacity.The launch extends the intelligence architecture underlying Dôr's Retail Intelligence platform into healthcare, reflecting Ai2's strategy of applying TAI to support product innovation and business growth.

Dôr Patient Journey is available now to qualified healthcare organizations. For more information or to request a demonstration, visit www.getdor.com.

About AIAI Holdings Corporation

AIAI Holdings Corporation (Ai2) (NASDAQ:AIAI) is an AI-enabled diversified holding company that acquires and grows companies across multiple industries. We expect to drive revenue and earnings growth throughout our portfolio by applying exclusively licensed Transformational AI to enhance operational efficiency and financial performance.

Ai2 is building a next-generation model for technology-enabled business operations, which is expected to create sustainable value for shareholders through the strategic integration of artificial intelligence across diverse industries.

About Dôr Technologies

Dôr Technologies builds privacy-first physical-intelligence platforms that connect real-world movement with operational systems and AI. Dôr's wireless sensing technology is deployed across more than 2,000 retail locations and serves as the physical-data foundation for Dôr Retail Intelligence. Dôr Patient Journey extends that architecture into healthcare operations by connecting anonymous physical flow with authorized clinical, scheduling, call-center, staffing and other operating data through an API-driven intelligence layer.

Dôr Technologies operates through Constellation Network, a portfolio company of AIAI Holdings Corporation.

About Constellation Network

Constellation Network is a technology company developing products at the intersection of AI, data infrastructure and blockchain. Its technologies connect trusted data, real-world operations and auditable digital infrastructure across commercial, enterprise and government environments. Learn more at www.constellationnetwork.io.

Constellation Network operates as a portfolio company of AIAI Holdings Corporation (NASDAQ:AIAI).

About Proactive MD

Proactive MD is a national Advanced Primary Care organization that partners with employers, patients and health plans to deliver comprehensive, patient-centered care. Its model includes dedicated and shared Health Centers, payer partnerships, pharmacy strategy, patient advocacy and coordinated services designed to support patients across the continuum of care. Learn more at www.proactive.md.

Cautionary Note Regarding Forward Looking Statements

This press release contains "forward-looking statements" or "forward-looking information" within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the plans, intentions, beliefs, and current expectations of the Company with respect to future business activities and plans of the Company. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation statements regarding our expectations, intentions, beliefs, plans, objectives, goals, strategies, future events or performance, and underlying assumptions. Forward-looking statements are often identified by the use of words such as "may," "will," "expect," "believe," "anticipate," "intend," "would," "could," "should", "estimate," "plan," "predict," "project," "estimate", or "continue," or similar expressions, including the negative of these terms or other comparable terminology.

Forward-looking statements are based on the Company's current expectations regarding its strategy, plans, intentions, performance, or future occurrences or results, the information on which such expectations were based may change. These forward-looking statements rely on a number of assumptions concerning future events and are subject to a number of known and unknown risks, uncertainties, and other factors, many of which are outside of the Company's control, that could cause actual results, performance, or achievements to materially differ from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such risks, uncertainties and other factors include, but are not limited to our lack of operating history, our ability to attract new investments, our failure to manage growth effectively, our acquisition activities may pose risks that could harm our business, and our licensed AI may not perform up to the expected standards, as well as general business and economic conditions, competitive pressures, regulatory changes, technological developments, and other factors identified in the Company's most recent filings with the U.S. Securities and Exchange Commission, including our Registration Statement on Form S-1, which are available for review at www.sec.gov. Furthermore, the Company operates in a competitive environment where new and unanticipated risks may arise. Accordingly, investors should not place any reliance on forward-looking statements as a prediction of actual results.

The forward-looking statements in this press release are based on information available to us as of the date hereof, and we disclaim any intention to, and, except as may be required by law, undertake no obligation to, update or revise forward-looking statements to reflect events or circumstances that subsequently occur or of which the Company hereafter become aware. These forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date of this press release.

Investor Relations

Matthew Selinger, Senior Partner
Integrous Communications
Email: [email protected]
Phone: 415-572-8152

Visit and follow AIAI Holdings Corporation online:

Website: AIAI Holdings
LinkedIn: AIAI LinkedIn
X/Twitter: AIAI X | Twitter
Instagram: AIAI Instagram
Facebook: AIAI Facebook

SOURCE: AIAI Holdings

Ryder System, Inc. (R) Morgan Stanley's 14th Annual Laguna Conference September 16, 2026 4:50 PM EDT

Company Participants

Cristina Gallo-Aquino - CFO, EVP & Principal Accounting Officer

Presentation

Unknown Analyst

Fantastic. Let's keep it going here, but also change gears a little bit. And very happy to welcome back to Laguna again, Ryder and very happy to have EVP and CFO, Cristina Gallo-Aquino. Thank you so much for being here.

Cristina Gallo-Aquino
CFO, EVP & Principal Accounting Officer

All right. Thank you for having me.

Question-and-Answer Session

Unknown Analyst

So plenty to talk about, given your diversification, given all your segments and kind of obviously, a lot of the tech trends as well. But maybe let's just start at a high level kind of when you look across the business right now and look at the cycle, which obviously has been a big topic of discussion here at this conference so far. How do you see things?

Cristina Gallo-Aquino
CFO, EVP & Principal Accounting Officer

Yes. Well, we've done a lot to transform our business, as you said. And we've had 7 consecutive quarters of earnings growth. And really, we've done that by consistent execution on our balanced growth strategy, which we've been talking about for quite a few years. And it's great to see now how that strategy has demonstrated that we have a very resilient business model that has been able to perform well during the last few years of this freight downturn. So what we've done is really what we've created a structural change in the business. And we think it's provided the right foundation, a solid foundation with good quality contracts that's really going to lead us into the next phase of this market and the recovery when it comes. We've all been anxiously awaiting.

TORONTO, ON / ACCESS Newswire / September 16, 2026 / Canada's Top 40 Under 40® 2026 Honourees have been officially announced today by Media Partner Financial Post. The program is owned by Founding Partner Caldwell (TSX:CWL), and supported by Presenting Partner Tourmaline Oil Corp. Additional partners of the program are National Sponsor Deloitte Canada, Travel Partner Air Canada, and Event Sponsor Ewing Morris & Co.; with fact checking and verification done by Inline Reference Check.

Canada's Top 40 Under 40 independent Advisory Board, which comprises 18 respected industry leaders from across Canada, met on June 10, 2026 to select the Honourees from a short list put together by Caldwell.

"On behalf of our program partners, I offer my sincere congratulations to the 2026 honourees," said Jeff Freeborough, managing partner for Toronto at Caldwell. "This year's honourees are an impressive and inspiring group of leaders. They are accomplished in their fields, committed to their communities and already making a meaningful impact across Canada. I'd also like to thank our partners for their continued commitment to this important program. Their support helps us recognize and celebrate exceptional Canadian leadership, bring greater visibility to the people shaping our country, and inspire the next generation of leaders."

The honourees were announced this morning on FinancialPost.com and will be featured in the Financial Post online and in print on October 21.

"I was honoured to be part of this year's selection process as a member of the Top 40 Advisory Board," said Mike Rose, President, CEO & Chair of Tourmaline Oil Corp. "As an alumnus of the award, I'm proud to see the program continue its legacy of identifying and recognizing the exceptional talent and leadership we have across Canada. This year's honourees are an accomplished and diverse group, representing the range of industries, organizations and regions across the country. After three decades of celebrating Canada's most promising leaders, this year's cohort serves as a reminder that the future of leadership in Canada looks bright. Congratulations to all the honourees on this most deserving recognition!"

Recipients will gather this evening in Toronto at an event hosted by Deloitte Canada to celebrate the announcement, and they will be honoured at the Top 40 National Celebrations to be held in Toronto in October, including the Top 40 Awards Night at Malaparte in the TIFF Lightbox on the night of October 21, 2026.

"Ewing Morris is delighted to be part of Canada's Top 40 Under 40," added Darcy Morris, CEO and Co-founder of Ewing Morris & Co. Investment Partners, and Advisory Board Member. "More than ever, it's important to celebrate and recognize the leaders who are not only contributing to Canada's economic success, but also strengthening our communities. We look forward to coming together in October to celebrate the achievements of this year's Top 40."

The 2026 Recipients of Canada's Top 40 Under 40 are:

Natalie Adomait
Managing Partner & COO, Brookfield Energy

Dahabo Ahmed-Omer
Chief Executive Officer, BlackNorth Initiative

Mark Ang
Co-founder & CEO, GoBolt

Ravipal Bains
Director & Senior Counsel, BCI

Dr. Arinjay Banerjee
Scientist, Vaccine and Infectious Disease Organization, University of Saskatchewan

Kaytlyn Barber
National Lead of Infrastructure, Capital Projects & Sustainability, KPMG LLP

Dr. Michael Benoit
Assistant Professor, Dept of Mechanical & Mechatronics Engineering, University of Waterloo

Eric Carriere
Director, Lumber Sales & Sales Operations, West Fraser

Scarlett Crockatt
Chief Financial Officer, Calfrac Well Services

Dr. Laurence Deschamps-Laporte
Director, Montreal Center for International Studies (CÉRIUM) & Professor, Political Science, Université de Montréal

Daniel Eberhard
CEO & Founder, KOHO

Amanda Gaiotti
Partner, Corporate Development, Sagard

Agapi Gessesse,
Chief Executive Officer, CILAR

Aidan Gomez / Nick Frosst / Ivan Zhang
Co-founder & CEO / Co-founder / Co-founder, Cohere

Chris Haubrich
Vice President, Corporate Development, Versamet Royalties Corporation

Jamie Heard
VP, Capital Markets, Tourmaline Oil Corp

Ashley Hill
Founder & Executive Director, The PREP Academy

Peter Janzen
EVP & President, Intact Insurance

Dr. Abbas Jessani
Associate Professor and Academic Lead, Community Service Learning in Oral Health & Co-Director, Master of Health Science in Global Health Systems, Schulich School of Medicine and Dentistry, Western University

Morgan Klein-MacNeil
SVP & CIO, Global Technology & Solutions, TD Bank Group

Oliver David Krieg
President, Intelligent City

Dr. Robert Lennox
Scientific Director & Professor of Biology Ocean Tracking Network, Dalhousie University

Megan Leslie / Julian Mulia
CEO & Co-founder / CSO & Co-founder, NanoTess

Mike Murchison
Co-founder & CEO, Ada

Mark Nasr
EVP & COO, Air Canada

Dr. Long Nguyen
Medical Oncologist and Clinician Scientist, Princess Margaret Cancer Centre, University Health Network

Patrice Njoh
Partner, Technology & Transformation Consulting Leader of Service & Experience Transformation in Human Capital, Deloitte Canada

Dr. Nicolas Papernot
Associate Professor, University of Toronto

Matthew Parker-Jones
SVP, International Commercial Banking, Scotiabank

Vitaly Pecherskiy
Chief Executive Officer, StackAdapt

Alexandra Petre
Chief Executive Officer, Deep Sky

Paige Sandher
Co-Founder & COO, CouchHaus

Jonathan Sherman
Executive Chair, Cassels Brock & Blackwell LLP

Jag Sikham / Aman Bring
Co-Founder & CEO / Co-Founder & COO, East to West Group of Companies

Emma Stern
COO & Co-founder, Felix Health

Scott Stevenson
CEO & Co-founder, Spellbook

Dr. Jonathan Stokes
Assistant Professor, Department of Biochemistry and Biomedical Sciences, McMaster University

Adam Temple
CEO, Inline Group Inc.

Zoe Tisshaw / Brooke Johansen-Shumay
Co-Owners and Co-CEOs, Park & Fifth Clothing Co.

Stephanie Wetmore
Founder & Managing Partner, Chrysalis Collective

Founded in 1995 by Caldwell, Canada's Top 40 Under 40 has recognized more than 840 outstanding Canadians and remains the country's most coveted award for young leaders. Alumni of the program include hundreds of nationally and internationally recognized CEOs, senior executives, community leaders and entrepreneurs.

For the full list of honourees and alumni, please visit: Canadastop40under40.com

About Caldwell
Caldwell is an elite executive search firm trusted by established and growth-focused companies alike. For more than 50 years we have partnered with clients to design and build extraordinary teams. Our partners don't just place leaders-they challenge assumptions, enable strategy, and prioritize long-term fit. Built through repeat clients and referrals, Caldwell delivers clarity and results without arrogance or shortcuts. For clients seeking substance over scale, we're the confident voice that listens-and leads. At Caldwell, our purpose is your mission.

Caldwell's common shares are listed on The Toronto Stock Exchange (TSX:CWL) and trade on the OTCQX Market (OTCQX:CWLPF). Please visit our website at https://www.caldwell.com/ for further information.

About Tourmaline
Tourmaline is a Canadian senior oil and natural gas company focused on long-term growth through an active exploration, development, production and acquisition program in the Western Canadian Sedimentary Basin.

For further information, please contact:

Michelle Jursa
Director, Programs
Caldwell
[email protected]
+1 416 934 2226

SOURCE: Caldwell Partners International, Inc.

Squarepoint Ops LLC decreased its stake in shares of Ryder System, Inc. (NYSE:R – Free Report) by 66.1% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 10,331 shares of the transportation company’s stock after selling 20,177 shares during the quarter. Squarepoint Ops LLC’s holdings in Ryder System were worth $2,725,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in the stock. Royal Bank of Canada grew its position in Ryder System by 52.8% during the 1st quarter. Royal Bank of Canada now owns 15,765 shares of the transportation company’s stock valued at $2,267,000 after purchasing an additional 5,448 shares during the last quarter. Focus Partners Wealth increased its position in shares of Ryder System by 7.9% during the first quarter. Focus Partners Wealth now owns 1,851 shares of the transportation company’s stock valued at $266,000 after acquiring an additional 135 shares in the last quarter. Geneos Wealth Management Inc. increased its position in shares of Ryder System by 61.2% during the first quarter. Geneos Wealth Management Inc. now owns 287 shares of the transportation company’s stock valued at $41,000 after acquiring an additional 109 shares in the last quarter. Northwestern Mutual Wealth Management Co. raised its holdings in Ryder System by 10.2% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 1,191 shares of the transportation company’s stock worth $189,000 after acquiring an additional 110 shares during the last quarter. Finally, M&T Bank Corp raised its holdings in Ryder System by 10.9% in the 2nd quarter. M&T Bank Corp now owns 2,153 shares of the transportation company’s stock worth $343,000 after acquiring an additional 212 shares during the last quarter. 87.47% of the stock is owned by institutional investors.

Ryder System Trading Up 0.2% NYSE:R opened at $243.67 on Monday. The company has a market cap of $9.34 billion, a PE ratio of 19.83 and a beta of 1.01. The company has a current ratio of 0.65, a quick ratio of 0.65 and a debt-to-equity ratio of 1.91. The company has a 50 day simple moving average of $258.51 and a two-hundred day simple moving average of $242.15. Ryder System, Inc. has a 12 month low of $157.67 and a 12 month high of $284.25.

Ryder System (NYSE:R – Get Free Report) last released its quarterly earnings results on Thursday, July 23rd. The transportation company reported $3.73 earnings per share for the quarter, beating the consensus estimate of $3.69 by $0.04. The firm had revenue of $2.69 billion for the quarter, compared to analysts’ expectations of $3.29 billion. Ryder System had a return on equity of 18.28% and a net margin of 3.88%.The company’s revenue was up 5.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $3.32 EPS. Ryder System has set its FY 2026 guidance at 14.400-14.800 EPS and its Q3 2026 guidance at 4.000-4.200 EPS. Research analysts forecast that Ryder System, Inc. will post 14.74 earnings per share for the current year. Ryder System Increases Dividend The company also recently declared a quarterly dividend, which will be paid on Friday, September 18th. Shareholders of record on Monday, August 24th will be paid a dividend of $1.01 per share. The ex-dividend date is Monday, August 24th. This represents a $4.04 dividend on an annualized basis and a dividend yield of 1.7%. This is an increase from Ryder System’s previous quarterly dividend of $0.91. Ryder System’s dividend payout ratio is presently 32.87%.

Analyst Upgrades and Downgrades R has been the topic of several recent analyst reports. Wells Fargo & Company increased their target price on Ryder System from $290.00 to $300.00 and gave the company an “overweight” rating in a research note on Friday, July 24th. Citigroup boosted their price target on Ryder System from $280.00 to $283.00 and gave the stock a “neutral” rating in a research note on Friday, July 24th. Wall Street Zen downgraded Ryder System from a “strong-buy” rating to a “buy” rating in a report on Saturday. Stephens raised Ryder System to a “strong-buy” rating in a research report on Wednesday, July 8th. Finally, Susquehanna lifted their price objective on Ryder System from $290.00 to $310.00 and gave the stock a “positive” rating in a report on Friday, July 24th. One equities research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $294.14.

View Our Latest Analysis on Ryder System

Ryder System Profile (Free Report)

Ryder System, Inc is a transportation and logistics company that provides fleet management, supply chain and dedicated transportation services. The company serves commercial customers across industries, helping them manage the movement, storage and delivery of goods through integrated transportation and logistics solutions.

Ryder’s fleet management offerings include commercial truck leasing, rental, maintenance and related support services. It also sells used vehicles and provides technology designed to help customers monitor fleets, improve utilization and manage transportation operations.

Featured Stories Five stocks we like better than Ryder System Why Bitcoin ETFs May Be Worth Another Look as Inflows Rebound 3 Small-Cap Biotechs With Binary Catalysts on the Calendar Planet Labs Has Fallen Back to Earth, But Wall Street Still Sees a Rebound As Homeowners’ Premiums Surge, This Insurer Is Posting Record Profits

Receive News & Ratings for Ryder System Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryder System and related companies with MarketBeat.com's FREE daily email newsletter.